Sample_series_id,library name,title,source name,organism,molecule,description,processed data file ,raw file,single or paired-end,instrument model,Sample characteristics
GSE185234,Mock_1,"mock infection, replicate 1",human fetal foreskin fibroblasts,human,transposon tagged DNA,followed ATACseq protocol,Mock_1.bedgraph,Mock_1_R1.fq.gz;Mock_1_R2.fq.gz,NA,NA,NA
GSE185234,Mock_2,"mock infection, replicate 2",human fetal foreskin fibroblasts,human,transposon tagged DNA,followed ATACseq protocol,Mock_2.bedgraph,Mock_2_R1.fq.gz;Mock_2_R2.fq.gz,NA,NA,NA
GSE185234,WT_1,"HSV-1 wt, strain 17, replicate 1",human fetal foreskin fibroblasts,human,transposon tagged DNA,followed ATACseq protocol,WT_1.bedgraph,WT_1_R1.fq.gz;WT_1_R2.fq.gz,NA,NA,infection status:8 hpi&&virus strain:strain 17&&
GSE185234,WT_2,"HSV-1 wt, strain 17, replicate 2",human fetal foreskin fibroblasts,human,transposon tagged DNA,followed ATACseq protocol,WT_2.bedgraph,WT_2_R1.fq.gz;WT_2_R2.fq.gz,NA,NA,infection status:8 hpi&&virus strain:strain 17&&
GSE185234,WT_plus_PAA_1,"HSV-1 wt, strain 17, +PAA, replicate 1",human fetal foreskin fibroblasts,human,transposon tagged DNA,followed ATACseq protocol,WT_plus_PAA_1.bedgraph,WT_plus_PAA_1_R1.fq.gz;WT_plus_PAA_1_R2.fq.gz,NA,NA,infection status:8 hpi&&treatment:PAA 300ug/ml&&virus strain:strain 17&&
GSE185234,WT_plus_PAA_2,"HSV-1 wt, strain 17, +PAA, replicate 2",human fetal foreskin fibroblasts,human,transposon tagged DNA,followed ATACseq protocol,WT_plus_PAA_2.bedgraph,WT_plus_PAA_2_R1.fq.gz;WT_plus_PAA_2_R2.fq.gz,NA,NA,infection status:8 hpi&&treatment:PAA 300ug/ml&&virus strain:strain 17&&
GSE185234,dICP0_1,"HSV-1 lacking expression of ICP0, replicate 1",human fetal foreskin fibroblasts,human,transposon tagged DNA,followed ATACseq protocol,dICP0_1.bedgraph,dICP0_1_R1.fq.gz;dICP0_1_R2.fq.gz,NA,NA,"infection status:12 hpi&&virus strain:strain 17, dl1403&&"
GSE185234,dICP0_2,"HSV-1 lacking expression of ICP0, replicate 2",human fetal foreskin fibroblasts,human,transposon tagged DNA,followed ATACseq protocol,dICP0_2.bedgraph,dICP0_2_R1.fq.gz;dICP0_2_R2.fq.gz,NA,NA,"infection status:12 hpi&&virus strain:strain 17, dl1403&&"
GSE185234,dICP22_1,"HSV-1 lacking expression of ICP22, HSV-1 strain F mutant R325, replicate 1",human fetal foreskin fibroblasts,human,transposon tagged DNA,followed ATACseq protocol,dICP22_1.bedgraph,dICP22_1_R1.fq.gz;dICP22_1_R2.fq.gz,NA,NA,"infection status:12 hpi&&virus strain:strain F, R325&&"
GSE185234,dICP22_2,"HSV-1 lacking expression of ICP22, HSV-1 strain F mutant R325, replicate 2",human fetal foreskin fibroblasts,human,transposon tagged DNA,followed ATACseq protocol,dICP22_2.bedgraph,dICP22_2_R1.fq.gz;dICP22_2_R2.fq.gz,NA,NA,"infection status:12 hpi&&virus strain:strain F, R325&&"
GSE185234,dICP22_3,"HSV-1 lacking expression of ICP22, HSV-1 strain F mutant R325, replicate 3",human fetal foreskin fibroblasts,human,transposon tagged DNA,followed ATACseq protocol,dICP22_3.bedgraph,dICP22_3_R1.fq.gz;dICP22_3_R2.fq.gz,NA,NA,"infection status:12 hpi&&virus strain:strain F, R325&&"
GSE185234,dICP22_4,"HSV-1 lacking expression of ICP22, HSV-1 strain F mutant R325, replicate 4",human fetal foreskin fibroblasts,human,transposon tagged DNA,followed ATACseq protocol,dICP22_4.bedgraph,dICP22_4_R1.fq.gz;dICP22_4_R2.fq.gz,NA,NA,"infection status:12 hpi&&virus strain:strain F, R325&&"
GSE185234,dICP22_plus_PAA_1,"HSV-1 lacking expression of ICP22, HSV-1 strain F mutant R325, +PAA, replicate 1",human fetal foreskin fibroblasts,human,transposon tagged DNA,followed ATACseq protocol,dICP22_plus_PAA_1.bedgraph,dICP22_plus_PAA_1_R1.fq.gz;dICP22_plus_PAA_1_R2.fq.gz,NA,NA,"infection status:12 hpi&&treatment:PAA 300ug/ml&&virus strain:strain F, R325&&"
GSE185234,dICP22_plus_PAA_2,"HSV-1 lacking expression of ICP22, HSV-1 strain F mutant R325, +PAA, replicate 2",human fetal foreskin fibroblasts,human,transposon tagged DNA,followed ATACseq protocol,dICP22_plus_PAA_2.bedgraph,dICP22_plus_PAA_2_R1.fq.gz;dICP22_plus_PAA_2_R2.fq.gz,NA,NA,"infection status:12 hpi&&treatment:PAA 300ug/ml&&virus strain:strain F, R325&&"
GSE185234,dICP27_1,"HSV-1 lacking expression of ICP27, KOS, replicate 1",human fetal foreskin fibroblasts,human,transposon tagged DNA,followed ATACseq protocol,dICP27_1.bedgraph,dICP27_1_R1.fq.gz;dICP27_1_R2.fq.gz,NA,NA,"infection status:8 hpi&&virus strain:strain KOS, 27LacZ&&"
GSE185234,dICP27_2,"HSV-1 lacking expression of ICP27, KOS, replicate 2",human fetal foreskin fibroblasts,human,transposon tagged DNA,followed ATACseq protocol,dICP27_2.bedgraph,dICP27_2_R1.fq.gz;dICP27_2_R2.fq.gz,NA,NA,"infection status:8 hpi&&virus strain:strain KOS, 27LacZ&&"
GSE185234,dVHS_1,"HSV-1 lacking expression of UL41, replicate 1",human fetal foreskin fibroblasts,human,transposon tagged DNA,followed ATACseq protocol,dVHS_1.bedgraph,dVHS_1_R1.fq.gz;dVHS_1_R2.fq.gz,NA,NA,infection status:8 hpi&&virus strain:strain 17&&
GSE185234,dVHS_2,"HSV-1 lacking expression of UL41, replicate 2",human fetal foreskin fibroblasts,human,transposon tagged DNA,followed ATACseq protocol,dVHS_2.bedgraph,dVHS_2_R1.fq.gz;dVHS_2_R2.fq.gz,NA,NA,infection status:8 hpi&&virus strain:strain 17&&
GSE185235,Delta_ICP22_12hpi_1,"HFFF cells infected with ICP22-null mutant (12 hpi), replicate 1",ATAC-seq,Homo sapiens sapiens,DNA,DNA isolated with MinElute PCR Purification Kit,Delta_ICP22_12hpi_1.bedgraph,L1901237_Nr15_Delta_ICP22_12hpi_R1.fq.gz;L1901237_Nr15_Delta_ICP22_12hpi_R2.fq.gz,NA,NA,"cell type:Primary human fetal foreskin fibroblasts (HFFF)&&Time post infection:12 hpi&&Treatment :no treatment&&Infection with:ICP22-null mutant of herpes simplex virus 1, strain F&&"
GSE185235,Delta_ICP22_12hpi_2,"HFFF cells infected with ICP22-null mutant (12 hpi), replicate 2",ATAC-seq,Homo sapiens sapiens,DNA,DNA isolated with MinElute PCR Purification Kit,Delta_ICP22_12hpi_2.bedgraph,Nr30_dICP22_12_hpi_DNA_R1.fq.gz;Nr30_dICP22_12_hpi_DNA_R2.fq.gz,NA,NA,"cell type:Primary human fetal foreskin fibroblasts (HFFF)&&Time post infection:12 hpi&&Treatment :no treatment&&Infection with:ICP22-null mutant of herpes simplex virus 1, strain F&&"
GSE185235,Delta_ICP22_8hpi_1,"HFFF cells infected with ICP22-null mutant (8 hpi), replicate 1",ATAC-seq,Homo sapiens sapiens,DNA,DNA isolated with MinElute PCR Purification Kit,Delta_ICP22_8hpi_1.bedgraph,L1901231_Nr07_Delta_ICP22_8hpi_R1.fq.gz;L1901231_Nr07_Delta_ICP22_8hpi_R2.fq.gz,NA,NA,"cell type:Primary human fetal foreskin fibroblasts (HFFF)&&Time post infection:8 hpi&&Treatment :no treatment&&Infection with:ICP22-null mutant of herpes simplex virus 1, strain F&&"
GSE185235,Delta_ICP22_8hpi_2,"HFFF cells infected with ICP22-null mutant (12 hpi), replicate 2",ATAC-seq,Homo sapiens sapiens,DNA,DNA isolated with MinElute PCR Purification Kit,Delta_ICP22_8hpi_2.bedgraph,Nr24_dICP22_8hpi_DNA_R1.fq.gz;Nr24_dICP22_8hpi_DNA_R2.fq.gz,NA,NA,"cell type:Primary human fetal foreskin fibroblasts (HFFF)&&Time post infection:12 hpi&&Treatment :no treatment&&Infection with:ICP22-null mutant of herpes simplex virus 1, strain F&&"
GSE185235,Delta_ICPP22_12hpi_plus_12hPAA_1,"HFFF cells infected with ICP22-null mutant (12 hpi), treated with PAA, replicate 1",ATAC-seq,Homo sapiens sapiens,DNA,DNA isolated with MinElute PCR Purification Kit,Delta_ICPP22_12hpi_plus_12hPAA_1.bedgraph,L1901238_Nr16_Delta_ICPP22_12hpi_plus_12hPAA_R1.fq.gz;L1901238_Nr16_Delta_ICPP22_12hpi_plus_12hPAA_R2.fq.gz,NA,NA,"cell type:Primary human fetal foreskin fibroblasts (HFFF)&&Time post infection:12 hpi&&Treatment :PAA (350 µg/ml)&&Infection with:ICP22-null mutant of herpes simplex virus 1, strain F&&"
GSE185235,Delta_ICPP22_12hpi_plus_12hPAA_2,"HFFF cells infected with ICP22-null mutant (12 hpi), treated with PAA, replicate 2",ATAC-seq,Homo sapiens sapiens,DNA,DNA isolated with MinElute PCR Purification Kit,Delta_ICPP22_12hpi_plus_12hPAA_2.bedgraph,Nr31_dICP22_12_hpi+PAA_DNA_R1.fq.gz;Nr31_dICP22_12_hpi+PAA_DNA_R2.fq.gz,NA,NA,"cell type:Primary human fetal foreskin fibroblasts (HFFF)&&Time post infection:12 hpi&&Treatment :PAA (350 µg/ml)&&Infection with:ICP22-null mutant of herpes simplex virus 1, strain F&&"
GSE185235,Delta_ICPP22_8hpi_plus_8hPAA_1,"HFFF cells infected with ICP22-null mutant (8 hpi), treated with PAA, replicate 1",ATAC-seq,Homo sapiens sapiens,DNA,DNA isolated with MinElute PCR Purification Kit,Delta_ICPP22_8hpi_plus_8hPAA_1.bedgraph,L1901232_Nr08_Delta_ICPP22_8hpi_plus_8hPAA_R1.fq.gz;L1901232_Nr08_Delta_ICPP22_8hpi_plus_8hPAA_R2.fq.gz,NA,NA,"cell type:Primary human fetal foreskin fibroblasts (HFFF)&&Time post infection:8 hpi&&Treatment :PAA (350 µg/ml)&&Infection with:ICP22-null mutant of herpes simplex virus 1, strain F&&"
GSE185235,Delta_ICPP22_8hpi_plus_8hPAA_2,"HFFF cells infected with ICP22-null mutant (8 hpi), treated with PAA, replicate 2",ATAC-seq,Homo sapiens sapiens,DNA,DNA isolated with MinElute PCR Purification Kit,Delta_ICPP22_8hpi_plus_8hPAA_2.bedgraph,Nr25_dICP22_8hpi+PAA_DNA_R1.fq.gz;Nr25_dICP22_8hpi+PAA_DNA_R2.fq.gz,NA,NA,"cell type:Primary human fetal foreskin fibroblasts (HFFF)&&Time post infection:8 hpi&&Treatment :PAA (350 µg/ml)&&Infection with:ICP22-null mutant of herpes simplex virus 1, strain F&&"
GSE185235,Mock_12h_1,"HFFF cells mock infected (12 hpi), replicate 1",ATAC-seq,Homo sapiens sapiens,DNA,DNA isolated with MinElute PCR Purification Kit,Mock_12h_1.bedgraph,L1901233_Nr09_Mock_12h_R1.fq.gz;L1901233_Nr09_Mock_12h_R2.fq.gz,NA,NA,cell type:Primary human fetal foreskin fibroblasts (HFFF)&&Time post infection:no infection&&Treatment :no treatment&&Infection with:no infection&&
GSE185235,Mock_12h_2,"HFFF cells mock infected (12 hpi), replicate 2",ATAC-seq,Homo sapiens sapiens,DNA,DNA isolated with MinElute PCR Purification Kit,Mock_12h_2.bedgraph,Nr26_Mock_12_hpi_DNA_R1.fq.gz;Nr26_Mock_12_hpi_DNA_R2.fq.gz,NA,NA,cell type:Primary human fetal foreskin fibroblasts (HFFF)&&Time post infection:no infection&&Treatment :no treatment&&Infection with:no infection&&
GSE185235,Mock_12h_plus_12hPAA_1,"HFFF cells mock infected (12 hpi), treated with PAA, replicate 1",ATAC-seq,Homo sapiens sapiens,DNA,DNA isolated with MinElute PCR Purification Kit,Mock_12h_plus_12hPAA_1.bedgraph,L1901234_Nr10_Mock_12h_plus_12hPAA_R1.fq.gz;L1901234_Nr10_Mock_12h_plus_12hPAA_R2.fq.gz,NA,NA,cell type:Primary human fetal foreskin fibroblasts (HFFF)&&Time post infection:no infection&&Treatment :PAA (350 µg/ml)&&Infection with:no infection&&
GSE185235,Mock_12h_plus_12hPAA_2,"HFFF cells mock infected (12 hpi), treated with PAA, replicate 2",ATAC-seq,Homo sapiens sapiens,DNA,DNA isolated with MinElute PCR Purification Kit,Mock_12h_plus_12hPAA_2.bedgraph,Nr27_Mock_12_hpi+PAA_DNA_R1.fq.gz;Nr27_Mock_12_hpi+PAA_DNA_R2.fq.gz,NA,NA,cell type:Primary human fetal foreskin fibroblasts (HFFF)&&Time post infection:no infection&&Treatment :PAA (350 µg/ml)&&Infection with:no infection&&
GSE185235,Mock_8h_2,"HFFF cells mock infected (8 hpi), replicate 2",ATAC-seq,Homo sapiens sapiens,DNA,DNA isolated with MinElute PCR Purification Kit,Mock_8h_2.bedgraph,Nr20_Mock_8_hpi_DNA_R1.fq.gz;Nr20_Mock_8_hpi_DNA_R2.fq.gz,NA,NA,cell type:Primary human fetal foreskin fibroblasts (HFFF)&&Time post infection:no infection&&Treatment :no treatment&&Infection with:no infection&&
GSE185235,Mock_8h_plus_8hPAA_2,"HFFF cells mock infected (8 hpi), treated with PAA, replicate 2",ATAC-seq,Homo sapiens sapiens,DNA,DNA isolated with MinElute PCR Purification Kit,Mock_8h_plus_8hPAA_2.bedgraph,Nr21_Mock_8_hpi+PAA_DNA_R1.fq.gz;Nr21_Mock_8_hpi+PAA_DNA_R2.fq.gz,NA,NA,cell type:Primary human fetal foreskin fibroblasts (HFFF)&&Time post infection:no infection&&Treatment :PAA (350 µg/ml)&&Infection with:no infection&&
GSE185235,Wt_F_12_hpi_1,"HFFF cells infected with HSV-1 WT (12 hpi), replicate 1",ATAC-seq,Homo sapiens sapiens,DNA,DNA isolated with MinElute PCR Purification Kit,Wt_F_12_hpi_1.bedgraph,L1901235_Nr13_Wt_F_12_hpi_R1.fq.gz;L1901235_Nr13_Wt_F_12_hpi_R2.fq.gz,NA,NA,"cell type:Primary human fetal foreskin fibroblasts (HFFF)&&Time post infection:12 hpi&&Treatment :no treatment&&Infection with:Herpes simplex virus 1, strain F&&"
GSE185235,Wt_F_12_hpi_2,"HFFF cells infected with HSV-1 WT (12 hpi), replicate 2",ATAC-seq,Homo sapiens sapiens,DNA,DNA isolated with MinElute PCR Purification Kit,Wt_F_12_hpi_2.bedgraph,Nr28_strain_F_12_hpi_DNA_R1.fq.gz;Nr28_strain_F_12_hpi_DNA_R2.fq.gz,NA,NA,"cell type:Primary human fetal foreskin fibroblasts (HFFF)&&Time post infection:12 hpi&&Treatment :no treatment&&Infection with:Herpes simplex virus 1, strain F&&"
GSE185235,Wt_F_12_hpi_plus_12hPAA_1,"HFFF cells infected with HSV-1 WT (12 hpi), treated with PAA, replicate 1",ATAC-seq,Homo sapiens sapiens,DNA,DNA isolated with MinElute PCR Purification Kit,Wt_F_12_hpi_plus_12hPAA_1.bedgraph,L1901236_Nr14_Wt_F_12_hpi_plus_12hPAA_R1.fq.gz;L1901236_Nr14_Wt_F_12_hpi_plus_12hPAA_R2.fq.gz,NA,NA,"cell type:Primary human fetal foreskin fibroblasts (HFFF)&&Time post infection:12 hpi&&Treatment :PAA (350 µg/ml)&&Infection with:Herpes simplex virus 1, strain F&&"
GSE185235,Wt_F_12_hpi_plus_12hPAA_2,"HFFF cells infected with HSV-1 WT (12 hpi), treated with PAA, replicate 2",ATAC-seq,Homo sapiens sapiens,DNA,DNA isolated with MinElute PCR Purification Kit,Wt_F_12_hpi_plus_12hPAA_2.bedgraph,Nr29_strain_F_12_hpi+PAA_DNA_R1.fq.gz;Nr29_strain_F_12_hpi+PAA_DNA_R2.fq.gz,NA,NA,"cell type:Primary human fetal foreskin fibroblasts (HFFF)&&Time post infection:12 hpi&&Treatment :PAA (350 µg/ml)&&Infection with:Herpes simplex virus 1, strain F&&"
GSE185235,Wt_F_8_hpi_1,"HFFF cells infected with HSV-1 WT (8 hpi), replicate 1",ATAC-seq,Homo sapiens sapiens,DNA,DNA isolated with MinElute PCR Purification Kit,Wt_F_8_hpi_1.bedgraph,L1901229_Nr05_Wt_F_8_hpi_R1.fq.gz;L1901229_Nr05_Wt_F_8_hpi_R2.fq.gz,NA,NA,"cell type:Primary human fetal foreskin fibroblasts (HFFF)&&Time post infection:8 hpi&&Treatment :no treatment&&Infection with:Herpes simplex virus 1, strain F&&"
GSE185235,Wt_F_8_hpi_2,"HFFF cells infected with HSV-1 WT (8 hpi), replicate 2",ATAC-seq,Homo sapiens sapiens,DNA,DNA isolated with MinElute PCR Purification Kit,Wt_F_8_hpi_2.bedgraph,Nr22_strain_F_8hpi_DNA_R1.fq.gz;Nr22_strain_F_8hpi_DNA_R2.fq.gz,NA,NA,"cell type:Primary human fetal foreskin fibroblasts (HFFF)&&Time post infection:8 hpi&&Treatment :no treatment&&Infection with:Herpes simplex virus 1, strain F&&"
GSE185235,Wt_F_8_hpi_plus_8hPAA_1,"HFFF cells infected with HSV-1 WT (8 hpi), treated with PAA, replicate 1",ATAC-seq,Homo sapiens sapiens,DNA,DNA isolated with MinElute PCR Purification Kit,Wt_F_8_hpi_plus_8hPAA_1.bedgraph,L1901230_Nr06_Wt_F_8_hpi_plus_8hPAA_R1.fq.gz;L1901230_Nr06_Wt_F_8_hpi_plus_8hPAA_R2.fq.gz,NA,NA,"cell type:Primary human fetal foreskin fibroblasts (HFFF)&&Time post infection:8 hpi&&Treatment :PAA (350 µg/ml)&&Infection with:Herpes simplex virus 1, strain F&&"
GSE185235,Wt_F_8_hpi_plus_8hPAA_2,"HFFF cells infected with HSV-1 WT (8 hpi), treated with PAA, replicate 2",ATAC-seq,Homo sapiens sapiens,DNA,DNA isolated with MinElute PCR Purification Kit,Wt_F_8_hpi_plus_8hPAA_2.bedgraph,Nr23_strain_F_8hpi+PAA_DNA_R1.fq.gz;Nr23_strain_F_8hpi+PAA_DNA_R2.fq.gz,NA,NA,"cell type:Primary human fetal foreskin fibroblasts (HFFF)&&Time post infection:8 hpi&&Treatment :PAA (350 µg/ml)&&Infection with:Herpes simplex virus 1, strain F&&"
GSE185236,KD_SPT6_ICP22_minus_dox_1,"T-HF cells, with no SPT6 KD, infected with ICP22-null mutant, replicate 1",Omni-ATAC,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,KD_SPT6_ICP22_minus_dox_1.bedgraph,KD_6_ICP22_minus_dox_R1.fq.gz;KD_6_ICP22_minus_dox_R2.fq.gz,NA,NA,"Time post infection:8 hpi&&Cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&Treatment:PAA (350 µg/ml)&&Infection with:ICP22-null mutant of herpes simplex virus 1, strain F&&"
GSE185236,KD_SPT6_ICP22_minus_dox_2,"T-HF cells, with no SPT6 KD, infected with ICP22-null mutant, replicate 2",Omni-ATAC,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,KD_SPT6_ICP22_minus_dox_2.bedgraph,KD_7_ICP22_minus_dox_R1.fq.gz;KD_7_ICP22_minus_dox_R2.fq.gz,NA,NA,"Time post infection:8 hpi&&Cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&Treatment:PAA (350 µg/ml)&&Infection with:ICP22-null mutant of herpes simplex virus 1, strain F&&"
GSE185236,KD_SPT6_ICP22_plus_dox_1,"T-HF cells, with SPT6 KD, infected with ICP22-null mutant, replicate 1",Omni-ATAC,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,KD_SPT6_ICP22_plus_dox_1.bedgraph,KD_6_ICP22_plus_dox_R1.fq.gz;KD_6_ICP22_plus_dox_R2.fq.gz,NA,NA,"Time post infection:8 hpi&&Cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&Treatment:PAA (350 µg/ml) + DOX (1 μg/mL)&&Infection with:ICP22-null mutant of herpes simplex virus 1, strain F&&"
GSE185236,KD_SPT6_ICP22_plus_dox_2,"T-HF cells, with SPT6 KD, infected with ICP22-null mutant, replicate 2",Omni-ATAC,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,KD_SPT6_ICP22_plus_dox_2.bedgraph,KD_7_ICP22_plus_dox_R1.fq.gz;KD_7_ICP22_plus_dox_R2.fq.gz,NA,NA,"Time post infection:8 hpi&&Cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&Treatment:PAA (350 µg/ml) + DOX (1 μg/mL)&&Infection with:ICP22-null mutant of herpes simplex virus 1, strain F&&"
GSE185236,KD_SPT6_Mock_minus_dox_1,"T-HF cells, with no SPT6 KD, mock, replicate 1",Omni-ATAC,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,KD_SPT6_Mock_minus_dox_1.bedgraph,KD_6_Mock_minus_dox_R1.fq.gz;KD_6_Mock_minus_dox_R2.fq.gz,NA,NA,Time post infection:no infection&&Cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&Treatment:PAA (350 µg/ml)&&Infection with:no infection&&
GSE185236,KD_SPT6_Mock_minus_dox_2,"T-HF cells, with no SPT6 KD, mock, replicate 2",Omni-ATAC,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,KD_SPT6_Mock_minus_dox_2.bedgraph,KD_7_Mock_minus_dox_R1.fq.gz;KD_7_Mock_minus_dox_R2.fq.gz,NA,NA,Time post infection:no infection&&Cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&Treatment:PAA (350 µg/ml)&&Infection with:no infection&&
GSE185236,KD_SPT6_Mock_plus_dox_1,"T-HF cells, with SPT6 KD, mock, replicate 1",Omni-ATAC,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,KD_SPT6_Mock_plus_dox_1.bedgraph,KD_6_Mock_plus_dox_R1.fq.gz;KD_6_Mock_plus_dox_R2.fq.gz,NA,NA,Time post infection:no infection&&Cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&Treatment:PAA (350 µg/ml) + DOX (1 μg/mL)&&Infection with:no infection&&
GSE185236,KD_SPT6_Mock_plus_dox_2,"T-HF cells, with SPT6 KD, mock, replicate 2",Omni-ATAC,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,KD_SPT6_Mock_plus_dox_2.bedgraph,KD_7_Mock_plus_dox_R1.fq.gz;KD_7_Mock_plus_dox_R2.fq.gz,NA,NA,Time post infection:no infection&&Cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&Treatment:PAA (350 µg/ml) + DOX (1 μg/mL)&&Infection with:no infection&&
GSE185236,KD_SPT6_Wt_minus_dox_1,"T-HF cells, with no SPT6 KD, infected with WT strain F, replicate 1",Omni-ATAC,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,KD_SPT6_Wt_minus_dox_1.bedgraph,KD_6_Wt_minus_dox_R1.fq.gz;KD_6_Wt_minus_dox_R2.fq.gz,NA,NA,"Time post infection:8 hpi&&Cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&Treatment:PAA (350 µg/ml)&&Infection with:Herpes simplex virus 1, strain F&&"
GSE185236,KD_SPT6_Wt_minus_dox_2,"T-HF cells, with no SPT6 KD, infected with WT strain F, replicate 2",Omni-ATAC,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,KD_SPT6_Wt_minus_dox_2.bedgraph,KD_7_Wt_minus_dox_R1.fq.gz;KD_7_Wt_minus_dox_R2.fq.gz,NA,NA,"Time post infection:8 hpi&&Cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&Treatment:PAA (350 µg/ml)&&Infection with:Herpes simplex virus 1, strain F&&"
GSE185236,KD_SPT6_Wt_plus_dox_1,"T-HF cells, with SPT6 KD, infected with WT strain F, replicate 1",Omni-ATAC,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,KD_SPT6_Wt_plus_dox_1.bedgraph,KD_6_Wt_plus_dox_R1.fq.gz;KD_6_Wt_plus_dox_R2.fq.gz,NA,NA,"Time post infection:8 hpi&&Cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&Treatment:PAA (350 µg/ml) + DOX (1 μg/mL)&&Infection with:Herpes simplex virus 1, strain F&&"
GSE185236,KD_SPT6_Wt_plus_dox_2,"T-HF cells, with SPT6 KD, infected with WT strain F, replicate 2",Omni-ATAC,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,KD_SPT6_Wt_plus_dox_2.bedgraph,KD_7_Wt_plus_dox_R1.fq.gz;KD_7_Wt_plus_dox_R2.fq.gz,NA,NA,"Time post infection:8 hpi&&Cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&Treatment:PAA (350 µg/ml) + DOX (1 μg/mL)&&Infection with:Herpes simplex virus 1, strain F&&"
GSE185236,KD_SSRP1_ICP22_minus_dox_1,"T-HF cells, with no SSRP1 KD, infected with ICP22-null mutant, replicate 1",Omni-ATAC,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,KD_SSRP1_ICP22_minus_dox_1.bedgraph,KD_16_ICP22_minus_dox_R1.fq.gz;KD_16_ICP22_minus_dox_R2.fq.gz,NA,NA,"Time post infection:8 hpi&&Cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&Treatment:PAA (350 µg/ml)&&Infection with:ICP22-null mutant of herpes simplex virus 1, strain F&&"
GSE185236,KD_SSRP1_ICP22_minus_dox_2,"T-HF cells, with no SSRP1 KD, infected with ICP22-null mutant, replicate 2",Omni-ATAC,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,KD_SSRP1_ICP22_minus_dox_2.bedgraph,KD_17_ICP22_minus_dox_R1.fq.gz;KD_17_ICP22_minus_dox_R2.fq.gz,NA,NA,"Time post infection:8 hpi&&Cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&Treatment:PAA (350 µg/ml)&&Infection with:ICP22-null mutant of herpes simplex virus 1, strain F&&"
GSE185236,KD_SSRP1_ICP22_plus_dox_1,"T-HF cells, with SSRP1 KD, infected with ICP22-null mutant, replicate 1",Omni-ATAC,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,KD_SSRP1_ICP22_plus_dox_1.bedgraph,KD_16_ICP22_plus_dox_R1.fq.gz;KD_16_ICP22_plus_dox_R2.fq.gz,NA,NA,"Time post infection:8 hpi&&Cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&Treatment:PAA (350 µg/ml) + DOX (1 μg/mL)&&Infection with:ICP22-null mutant of herpes simplex virus 1, strain F&&"
GSE185236,KD_SSRP1_ICP22_plus_dox_2,"T-HF cells, with SSRP1 KD, infected with ICP22-null mutant, replicate 2",Omni-ATAC,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,KD_SSRP1_ICP22_plus_dox_2.bedgraph,KD_17_ICP22_plus_dox_R1.fq.gz;KD_17_ICP22_plus_dox_R2.fq.gz,NA,NA,"Time post infection:8 hpi&&Cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&Treatment:PAA (350 µg/ml) + DOX (1 μg/mL)&&Infection with:ICP22-null mutant of herpes simplex virus 1, strain F&&"
GSE185236,KD_SSRP1_Mock_minus_dox_1,"T-HF cells, with no SSRP1 KD, mock, replicate 1",Omni-ATAC,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,KD_SSRP1_Mock_minus_dox_1.bedgraph,KD_16_Mock_minus_dox_R1.fq.gz;KD_16_Mock_minus_dox_R2.fq.gz,NA,NA,Time post infection:no infection&&Cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&Treatment:PAA (350 µg/ml)&&Infection with:no infection&&
GSE185236,KD_SSRP1_Mock_minus_dox_2,"T-HF cells, with no SSRP1 KD, mock, replicate 2",Omni-ATAC,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,KD_SSRP1_Mock_minus_dox_2.bedgraph,KD_17_Mock_minus_dox_R1.fq.gz;KD_17_Mock_minus_dox_R2.fq.gz,NA,NA,Time post infection:no infection&&Cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&Treatment:PAA (350 µg/ml)&&Infection with:no infection&&
GSE185236,KD_SSRP1_Mock_plus_dox_1,"T-HF cells, with SSP1 KD, mock, replicate 1",Omni-ATAC,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,KD_SSRP1_Mock_plus_dox_1.bedgraph,KD_16_Mock_plus_dox_R1.fq.gz;KD_16_Mock_plus_dox_R2.fq.gz,NA,NA,Time post infection:no infection&&Cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&Treatment:PAA (350 µg/ml) + DOX (1 μg/mL)&&Infection with:no infection&&
GSE185236,KD_SSRP1_Mock_plus_dox_2,"T-HF cells, with SSRP1 KD, mock, replicate 2",Omni-ATAC,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,KD_SSRP1_Mock_plus_dox_2.bedgraph,KD_17_Mock_plus_dox_R1.fq.gz;KD_17_Mock_plus_dox_R2.fq.gz,NA,NA,Time post infection:no infection&&Cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&Treatment:PAA (350 µg/ml) + DOX (1 μg/mL)&&Infection with:no infection&&
GSE185236,KD_SSRP1_Wt_minus_dox_1,"T-HF cells, with no SSRP1 KD, infected with WT strain F, replicate 1",Omni-ATAC,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,KD_SSRP1_Wt_minus_dox_1.bedgraph,KD_16_Wt_minus_dox_R1.fq.gz;KD_16_Wt_minus_dox_R2.fq.gz,NA,NA,"Time post infection:8 hpi&&Cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&Treatment:PAA (350 µg/ml)&&Infection with:Herpes simplex virus 1, strain F&&"
GSE185236,KD_SSRP1_Wt_minus_dox_2,"T-HF cells, with no SSRP1 KD, infected with WT strain F, replicate 2",Omni-ATAC,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,KD_SSRP1_Wt_minus_dox_2.bedgraph,KD_17_Wt_minus_dox_R1.fq.gz;KD_17_Wt_minus_dox_R2.fq.gz,NA,NA,"Time post infection:8 hpi&&Cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&Treatment:PAA (350 µg/ml)&&Infection with:Herpes simplex virus 1, strain F&&"
GSE185236,KD_SSRP1_Wt_plus_dox_1,"T-HF cells, with SSRP1 KD, infected with WT strain F, replicate 1",Omni-ATAC,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,KD_SSRP1_Wt_plus_dox_1.bedgraph,KD_16_Wt_plus_dox_R1.fq.gz;KD_16_Wt_plus_dox_R2.fq.gz,NA,NA,"Time post infection:8 hpi&&Cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&Treatment:PAA (350 µg/ml) + DOX (1 μg/mL)&&Infection with:Herpes simplex virus 1, strain F&&"
GSE185236,KD_SSRP1_Wt_plus_dox_2,"T-HF cells, with SSRP1 KD, infected with WT strain F, replicate 2",Omni-ATAC,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,KD_SSRP1_Wt_plus_dox_2.bedgraph,KD_17_Wt_plus_dox_R1.fq.gz;KD_17_Wt_plus_dox_R2.fq.gz,NA,NA,"Time post infection:8 hpi&&Cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&Treatment:PAA (350 µg/ml) + DOX (1 μg/mL)&&Infection with:Herpes simplex virus 1, strain F&&"
GSE185238,V5_ICP27_plus_HA_ICP22_plus_DOX_1,"HA-ICP22+V5-ICP27 cells, DOX, replicate 1",Omni-ATAC-seq,Homo sapiens sapiens,DNA,DNA isolated with MinElute PCR Purification Kit,V5_ICP27_plus_HA_ICP22_plus_DOX_1_merged.bedgraph,2360_V5_ICP27_plus_HA_ICP22_plus_DOX_Repl_1_R1.fq.gz;2360_V5_ICP27_plus_HA_ICP22_plus_DOX_Repl_1_R2.fq.gz;V5_ICP27_plus_HA_ICP22_plus_DOX_Repl_1_R1.fq.gz;V5_ICP27_plus_HA_ICP22_plus_DOX_Repl_1_R2.fq.gz,NA,NA,Cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&Treatment :DOX (5 μg/mL);no treatment&&
GSE185238,V5_ICP27_plus_HA_ICP22_minus_DOX_1,"HA-ICP22+V5-ICP27 cells, no DOX, replicate 1",Omni-ATAC-seq,Homo sapiens sapiens,DNA,DNA isolated with MinElute PCR Purification Kit,V5_ICP27_plus_HA_ICP22_minus_DOX_1_merged.bedgraph,2361_V5_ICP27_plus_HA_ICP22_minus_DOX_Repl_1_R1.fq.gz;2361_V5_ICP27_plus_HA_ICP22_minus_DOX_Repl_1_R2.fq.gz;V5_ICP27_plus_HA_ICP22_minus_DOX_Repl_1_R1.fq.gz;V5_ICP27_plus_HA_ICP22_minus_DOX_Repl_1_R2.fq.gz,NA,NA,Cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&Treatment :no treatment;no treatment&&
GSE185238,V5_ICP27_plus_HA_ICP22_plus_DOX_2,"HA-ICP22+V5-ICP27 cells, DOX, replicate 2",Omni-ATAC-seq,Homo sapiens sapiens,DNA,DNA isolated with MinElute PCR Purification Kit,V5_ICP27_plus_HA_ICP22_plus_DOX_2_merged.bedgraph,2372_V5_ICP27_plus_HA_ICP22_plus_DOX_Repl_2_R1.fq.gz;2372_V5_ICP27_plus_HA_ICP22_plus_DOX_Repl_2_R2.fq.gz;V5_ICP27_plus_HA_ICP22_plus_DOX_Repl_2_R1.fq.gz;V5_ICP27_plus_HA_ICP22_plus_DOX_Repl_2_R2.fq.gz,NA,NA,Cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&Treatment :DOX (5 μg/mL);no treatment&&
GSE185238,V5_ICP27_plus_HA_ICP22_minus_DOX_2,"HA-ICP22+V5-ICP27 cells, no DOX, replicate 2",Omni-ATAC-seq,Homo sapiens sapiens,DNA,DNA isolated with MinElute PCR Purification Kit,V5_ICP27_plus_HA_ICP22_minus_DOX_2_merged.bedgraph,2373_V5_ICP27_plus_HA_ICP22_minus_DOX_Repl_2_R1.fq.gz;2373_V5_ICP27_plus_HA_ICP22_minus_DOX_Repl_2_R2.fq.gz;V5_ICP27_plus_HA_ICP22_minus_DOX_Repl_2_R1.fq.gz;V5_ICP27_plus_HA_ICP22_minus_DOX_Repl_2_R2.fq.gz,NA,NA,Cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&Treatment :no treatment;no treatment&&
GSE185238,HA_ICP22_Salt_stress_2h_plus_DOX_1,"HA-ICP22 cells, salt stress, DOX, replicate 1",Omni-ATAC-seq,Homo sapiens sapiens,DNA,DNA isolated with MinElute PCR Purification Kit,HA_ICP22_Salt_stress_2h_plus_DOX_1_merged.bedgraph,2356_HA_ICP22_Salt_stress_2h_plus_DOX_R1.fq.gz;2356_HA_ICP22_Salt_stress_2h_plus_DOX_R2.fq.gz;HA_ICP22_Salt_stress_2h_plus_DOX_R1.fq.gz;HA_ICP22_Salt_stress_2h_plus_DOX_R2.fq.gz,NA,NA,Cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&Treatment :DOX (5 μg/mL);80 mM KCl&&
GSE185238,HA_ICP22_Salt_Stress_2h_minus_DOX_1,"HA-ICP22 cells, salt stress, no DOX, replicate 1",Omni-ATAC-seq,Homo sapiens sapiens,DNA,DNA isolated with MinElute PCR Purification Kit,HA_ICP22_Salt_Stress_2h_minus_DOX_1_merged.bedgraph,2357_HA_ICP22_Salt_Stress_2h_minus_DOX_R1.fq.gz;2357_HA_ICP22_Salt_Stress_2h_minus_DOX_R2.fq.gz;HA_ICP22_Salt_Stress_2h_minus_DOX_R1.fq.gz;HA_ICP22_Salt_Stress_2h_minus_DOX_R2.fq.gz,NA,NA,Cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&Treatment :no treatment;80 mM KCl&&
GSE185238,HA_ICP22_Salt_stress_2h_plus_DOX_2,"HA-ICP22 cells, salt stress, DOX, replicate 2",Omni-ATAC-seq,Homo sapiens sapiens,DNA,DNA isolated with MinElute PCR Purification Kit,HA_ICP22_Salt_stress_2h_plus_DOX_2_merged.bedgraph,2368_HA_ICP22_Salt_stress_2h_plus_DOX_Rep2_R1.fq.gz;2368_HA_ICP22_Salt_stress_2h_plus_DOX_Rep2_R2.fq.gz;HA_ICP22_Salt_stress_2h_plus_DOX_2_rep_R1.fq.gz;HA_ICP22_Salt_stress_2h_plus_DOX_2_rep_R2.fq.gz,NA,NA,Cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&Treatment :DOX (5 μg/mL);80 mM KCl&&
GSE185238,HA_ICP22_Salt_Stress_2h_minus_DOX_2,"HA-ICP22 cells, salt stress, no DOX, replicate 2",Omni-ATAC-seq,Homo sapiens sapiens,DNA,DNA isolated with MinElute PCR Purification Kit,HA_ICP22_Salt_Stress_2h_minus_DOX_2_merged.bedgraph,2369_HA_ICP22_Salt_Stress_2h_minus_DOX_Rep2_R1.fq.gz;2369_HA_ICP22_Salt_Stress_2h_minus_DOX_Rep2_R2.fq.gz;HA_ICP22_Salt_Stress_2h_minus_DOX_2_rep_R1.fq.gz;HA_ICP22_Salt_Stress_2h_minus_DOX_2_rep_R2.fq.gz,NA,NA,Cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&Treatment :no treatment;80 mM KCl&&
GSE185238,Mock_HFFF_plus_PAA_1,"primary HFFF cells, Mock-infected, PAA 350ug/ml, replicate 1",Omni-ATAC-seq,Homo sapiens sapiens,DNA,DNA isolated with MinElute PCR Purification Kit,Mock_HFFF_plus_PAA_1.bedgraph,2330_Mock_HFFF_plus_PAA_R1.fq.gz;2330_Mock_HFFF_plus_PAA_R2.fq.gz,NA,NA,Cell type:primary Human Foetal Foreskin Fibroblast cells&&Treatment :350 ug'/ml PAA;Mock&&
GSE185238,Mock_HFFF_plus_PAA_2,"primary HFFF cells, Mock infected, PAA 350ug/ml, replicate 2",Omni-ATAC-seq,Homo sapiens sapiens,DNA,DNA isolated with MinElute PCR Purification Kit,Mock_HFFF_plus_PAA_2.bedgraph,2340_Mock_HFFF_plus_PAA_R1.fq.gz;2340_Mock_HFFF_plus_PAA_R2.fq.gz,NA,NA,Cell type:primary Human Foetal Foreskin Fibroblast cells&&Treatment :351 ug'/ml PAA;Mock&&
GSE185238,KOS_1_1_Wt_plus_PAA_1,"primary HFFF cells, infected with KOS 1.1 strain, PAA 350ug/ml, replicate 1",Omni-ATAC-seq,Homo sapiens sapiens,DNA,DNA isolated with MinElute PCR Purification Kit,KOS_1_1_Wt_plus_PAA_1.bedgraph,2336_KOS_1_1_Wt_plus_PAA_R1.fq.gz;2336_KOS_1_1_Wt_plus_PAA_R2.fq.gz,NA,NA,Cell type:primary Human Foetal Foreskin Fibroblast cells&&Treatment :352 ug'/ml PAA;WT KOS 1.1&&
GSE185238,KOS_1_1_Wt_plus_PAA_2,"primary HFFF cells, infected with KOS 1.1 strain, PAA 350ug/ml, replicate 2",Omni-ATAC-seq,Homo sapiens sapiens,DNA,DNA isolated with MinElute PCR Purification Kit,KOS_1_1_Wt_plus_PAA_2.bedgraph,2346_KOS_1_1_Wt_plus_PAA_R1.fq.gz;2346_KOS_1_1_Wt_plus_PAA_R2.fq.gz,NA,NA,Cell type:primary Human Foetal Foreskin Fibroblast cells&&Treatment :353 ug'/ml PAA;WT KOS 1.1&&
GSE185238,dICP22_lac_Z_V22_plus_PAA_1,"primary HFFF cells, infected with KOS 1.1 strain derived US1 knock-out,  PAA 350ug/ml, replicate 1",Omni-ATAC-seq,Homo sapiens sapiens,DNA,DNA isolated with MinElute PCR Purification Kit,dICP22_lac_Z_V22_plus_PAA_1.bedgraph,2339_dICP22_lac_Z__V22__plus_PAA_R1.fq.gz;2339_dICP22_lac_Z__V22__plus_PAA_R2.fq.gz,NA,NA,Cell type:primary Human Foetal Foreskin Fibroblast cells&&Treatment :354 ug'/ml PAA;KOS 1.1 with US1 deletion&&
GSE185238,dICP22_lac_Z_V22_plus_PAA_2,"primary HFFF cells, infected with KOS 1.1 strain derived US1 knock-out,  PAA 350ug/ml, replicate 2",Omni-ATAC-seq,Homo sapiens sapiens,DNA,DNA isolated with MinElute PCR Purification Kit,dICP22_lac_Z_V22_plus_PAA_2.bedgraph,2349_dICP22_lac_Z__V22__plus_PAA_R1.fq.gz;2349_dICP22_lac_Z__V22__plus_PAA_R2.fq.gz,NA,NA,Cell type:primary Human Foetal Foreskin Fibroblast cells&&Treatment :355 ug'/ml PAA;KOS 1.1 with US1 deletion&&
GSE185239,Delta_ICP22_12_hpi_2,"ICP22-null infection, 12h p.i., replicate 2",Total RNA,Homo sapiens sapiens,total RNA,Total RNA prepared using Trizol,gene_counts.tsv,Nr30_dICP22_12_hpi_RNA_R1.fq.gz;Nr30_dICP22_12_hpi_RNA_R2.fq.gz,NA,NA,"Time post infection:12 hpi&&Cell type:human fetal foreskin fibroblasts&&Infection with:ICP22-null mutant of herpes simplex virus 1, strain F&&treatment :no treatment&&"
GSE185239,Delta_ICP22_12hpi_1,"ICP22-null infection, 12h p.i., replicate 1",Total RNA,Homo sapiens sapiens,total RNA,Total RNA prepared using Trizol,gene_counts.tsv,L1901227_Nr15_Delta_ICP22_12hpi_R1.fq.gz;L1901227_Nr15_Delta_ICP22_12hpi_R2.fq.gz,NA,NA,"Time post infection:12 hpi&&Cell type:human fetal foreskin fibroblasts&&Infection with:ICP22-null mutant of herpes simplex virus 1, strain F&&treatment :no treatment&&"
GSE185239,Delta_ICP22_12hpi_plus_12hPAA_2,"ICP22-null infection, 12h p.i., PAA, replicate 2",Total RNA,Homo sapiens sapiens,total RNA,Total RNA prepared using Trizol,gene_counts.tsv,Nr31_dICP22_12_hpi+PAA_RNA_R1.fq.gz;Nr31_dICP22_12_hpi+PAA_RNA_R2.fq.gz,NA,NA,"Time post infection:12 hpi&&Cell type:human fetal foreskin fibroblasts&&Infection with:ICP22-null mutant of herpes simplex virus 1, strain F&&treatment :PAA (350 µg/ml)&&"
GSE185239,Delta_ICP22_8hpi_1,"ICP22-null infection, 8h p.i., replicate 1",Total RNA,Homo sapiens sapiens,total RNA,Total RNA prepared using Trizol,gene_counts.tsv,L1901221_Nr07_Delta_ICP22_8hpi_R1.fq.gz;L1901221_Nr07_Delta_ICP22_8hpi_R2.fq.gz,NA,NA,"Time post infection:8 hpi&&Cell type:human fetal foreskin fibroblasts&&Infection with:ICP22-null mutant of herpes simplex virus 1, strain F&&treatment :no treatment&&"
GSE185239,Delta_ICP22_8hpi_2,"ICP22-null infection, 8h p.i.,replicate 2",Total RNA,Homo sapiens sapiens,total RNA,Total RNA prepared using Trizol,gene_counts.tsv,Nr24_dICP22_8hpi_RNA_R1.fq.gz;Nr24_dICP22_8hpi_RNA_R2.fq.gz,NA,NA,"Time post infection:8 hpi&&Cell type:human fetal foreskin fibroblasts&&Infection with:ICP22-null mutant of herpes simplex virus 1, strain F&&treatment :no treatment&&"
GSE185239,Delta_ICP22_8hpi_plus_8hPAA_2,"ICP22-null infection, 8h p.i., PAA, replicate 2",Total RNA,Homo sapiens sapiens,total RNA,Total RNA prepared using Trizol,gene_counts.tsv,Nr25_dICP22_8hpi+PAA_RNA_R1.fq.gz;Nr25_dICP22_8hpi+PAA_RNA_R2.fq.gz,NA,NA,"Time post infection:8 hpi&&Cell type:human fetal foreskin fibroblasts&&Infection with:ICP22-null mutant of herpes simplex virus 1, strain F&&treatment :PAA (350 µg/ml)&&"
GSE185239,Delta_ICPP22_12hpi_plus_12hPAA_1,"ICP22-null infection, 12h p.i., PAA, replicate 1",Total RNA,Homo sapiens sapiens,total RNA,Total RNA prepared using Trizol,gene_counts.tsv,L1901228_Nr16_Delta_ICPP22_12hpi_plus_12hPAA_R1.fq.gz;L1901228_Nr16_Delta_ICPP22_12hpi_plus_12hPAA_R2.fq.gz,NA,NA,"Time post infection:12 hpi&&Cell type:human fetal foreskin fibroblasts&&Infection with:ICP22-null mutant of herpes simplex virus 1, strain F&&treatment :PAA (350 µg/ml)&&"
GSE185239,Delta_ICPP22_8hpi_plus_8hPAA_1,"ICP22-null infection, 8h p.i., PAA, replicate 1",Total RNA,Homo sapiens sapiens,total RNA,Total RNA prepared using Trizol,gene_counts.tsv,L1901222_Nr08_Delta_ICPP22_8hpi_plus_8hPAA_R1.fq.gz;L1901222_Nr08_Delta_ICPP22_8hpi_plus_8hPAA_R2.fq.gz,NA,NA,"Time post infection:8 hpi&&Cell type:human fetal foreskin fibroblasts&&Infection with:ICP22-null mutant of herpes simplex virus 1, strain F&&treatment :PAA (350 µg/ml)&&"
GSE185239,HA_ICP22_plus_V5_ICP27_cells_minus_DOX_RNA_1,"HA-ICP22+V5-ICP27 cells, no DOX, replicate 1",Total RNA,Homo sapiens sapiens,total RNA,Total RNA prepared using Trizol,gene_counts.tsv,2329_HA_ICP22_plus_V5_ICP27_cells_minus_DOX_R1.fq.gz;2329_HA_ICP22_plus_V5_ICP27_cells_minus_DOX_R2.fq.gz,NA,NA,Time post infection:no infection&&Cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&Infection with:no infection&&treatment :no treatment&&
GSE185239,HA_ICP22_plus_V5_ICP27_cells_minus_DOX_RNA_2,"HA-ICP22+V5-ICP27 cells, no DOX, replicate 2",Total RNA,Homo sapiens sapiens,total RNA,Total RNA prepared using Trizol,gene_counts.tsv,V5_ICP27_plus_HA_ICP22_minus_DOX_R1.fq.gz;V5_ICP27_plus_HA_ICP22_minus_DOX_R2.fq.gz,NA,NA,Time post infection:no infection&&Cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&Infection with:no infection&&treatment :no treatment&&
GSE185239,HA_ICP22_plus_V5_ICP27_cells_plus_DOX_RNA_1,"HA-ICP22+V5-ICP27 cells, DOX, replicate 1",Total RNA,Homo sapiens sapiens,total RNA,Total RNA prepared using Trizol,gene_counts.tsv,2328_HA_ICP22_plus_V5_ICP27_cells_plus_DOX_RNA_R1.fq.gz;2328_HA_ICP22_plus_V5_ICP27_cells_plus_DOX_RNA_R2.fq.gz,NA,NA,Time post infection:no infection&&Cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&Infection with:no infection&&treatment :DOX (5 μg/mL)&&
GSE185239,HA_ICP22_plus_V5_ICP27_cells_plus_DOX_RNA_2,"HA-ICP22+V5-ICP27 cells, DOX, replicate 2",Total RNA,Homo sapiens sapiens,total RNA,Total RNA prepared using Trizol,gene_counts.tsv,V5_ICP27_plus_HA_ICP22_plus_DOX_R1.fq.gz;V5_ICP27_plus_HA_ICP22_plus_DOX_R2.fq.gz,NA,NA,Time post infection:no infection&&Cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&Infection with:no infection&&treatment :DOX (5 μg/mL)&&
GSE185239,HA_ICP22_Salt_Stress_minus_DOX_RNA_1,"HA-ICP22 cells, salt stress, no DOX, replicate 1",Total RNA,Homo sapiens sapiens,total RNA,Total RNA prepared using Trizol,gene_counts.tsv,HA_ICP22_Salt_Stress_2h_minus_DOX_1_R1.fq.gz;HA_ICP22_Salt_Stress_2h_minus_DOX_1_R2.fq.gz,NA,NA,Time post infection:no infection&&Cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&Infection with:no infection&&treatment :KCl (80 mM)&&
GSE185239,HA_ICP22_Salt_Stress_minus_DOX_RNA_2,"HA-ICP22 cells, salt stress, no DOX, replicate 2",Total RNA,Homo sapiens sapiens,total RNA,Total RNA prepared using Trizol,gene_counts.tsv,HA_ICP22_Salt_Stress_2h_minus_DOX_2_R1.fq.gz;HA_ICP22_Salt_Stress_2h_minus_DOX_2_R2.fq.gz,NA,NA,Time post infection:no infection&&Cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&Infection with:no infection&&treatment :KCl (80 mM)&&
GSE185239,HA_ICP22_Salt_stress_plus_DOX_RNA_1,"HA-ICP22 cells, salt stress, DOX, replicate 1",Total RNA,Homo sapiens sapiens,total RNA,Total RNA prepared using Trizol,gene_counts.tsv,2326_HA_ICP22_Salt_stress_plus_DOX_RNA_R1.fq.gz;2326_HA_ICP22_Salt_stress_plus_DOX_RNA_R2.fq.gz,NA,NA,Time post infection:no infection&&Cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&Infection with:no infection&&treatment :DOX (5 μg/mL) + KCl (80 mM)&&
GSE185239,HA_ICP22_Salt_stress_plus_DOX_RNA_2,"HA-ICP22 cells, salt stress, DOX, replicate 2",Total RNA,Homo sapiens sapiens,total RNA,Total RNA prepared using Trizol,gene_counts.tsv,HA_ICP22_Salt_stress_2h_plus_DOX_R1.fq.gz;HA_ICP22_Salt_stress_2h_plus_DOX_R2.fq.gz,NA,NA,Time post infection:no infection&&Cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&Infection with:no infection&&treatment :DOX (5 μg/mL) + KCl (80 mM)&&
GSE185239,Mock_12_hpi_2,"mock infection, 12h p.i., replicate 2",Total RNA,Homo sapiens sapiens,total RNA,Total RNA prepared using Trizol,gene_counts.tsv,Nr26_Mock_12_hpi_RNA_R1.fq.gz;Nr26_Mock_12_hpi_RNA_R2.fq.gz,NA,NA,Time post infection:mock&&Cell type:human fetal foreskin fibroblasts&&Infection with:mock&&treatment :no treatment&&
GSE185239,Mock_12_hpi_plus_12hPAA_2,"mock infection, 12h p.i., PAA, replicate 2",Total RNA,Homo sapiens sapiens,total RNA,Total RNA prepared using Trizol,gene_counts.tsv,Nr27_Mock_12_hpi+PAA_RNA_R1.fq.gz;Nr27_Mock_12_hpi+PAA_RNA_R2.fq.gz,NA,NA,Time post infection:mock&&Cell type:human fetal foreskin fibroblasts&&Infection with:mock&&treatment :PAA (350 µg/ml)&&
GSE185239,Mock_12h_1,"mock infection, 12h p.i., replicate 1",Total RNA,Homo sapiens sapiens,total RNA,Total RNA prepared using Trizol,gene_counts.tsv,L1901223_Nr09_Mock_12h_R1.fq.gz;L1901223_Nr09_Mock_12h_R2.fq.gz,NA,NA,Time post infection:mock&&Cell type:human fetal foreskin fibroblasts&&Infection with:mock&&treatment :no treatment&&
GSE185239,Mock_12h_plus_12hPAA_1,"mock infection, 12h p.i., PAA, replicate 1",Total RNA,Homo sapiens sapiens,total RNA,Total RNA prepared using Trizol,gene_counts.tsv,L1901224_Nr10_Mock_12h_plus_12hPAA_R1.fq.gz;L1901224_Nr10_Mock_12h_plus_12hPAA_R2.fq.gz,NA,NA,Time post infection:mock&&Cell type:human fetal foreskin fibroblasts&&Infection with:mock&&treatment :PAA (350 µg/ml)&&
GSE185239,Mock_8_hpi_2,"mock infection, 8h p.i., replicate 2",Total RNA,Homo sapiens sapiens,total RNA,Total RNA prepared using Trizol,gene_counts.tsv,Nr20_Mock_8_hpi_RNA_R1.fq.gz;Nr20_Mock_8_hpi_RNA_R2.fq.gz,NA,NA,Time post infection:mock&&Cell type:human fetal foreskin fibroblasts&&Infection with:mock&&treatment :no treatment&&
GSE185239,Mock_8_hpi_plus_8hPAA_2,"mock infection, 8h p.i., PAA, replicate 2",Total RNA,Homo sapiens sapiens,total RNA,Total RNA prepared using Trizol,gene_counts.tsv,Nr21_Mock_8_hpi+PAA_RNA_R1.fq.gz;Nr21_Mock_8_hpi+PAA_RNA_R2.fq.gz,NA,NA,Time post infection:mock&&Cell type:human fetal foreskin fibroblasts&&Infection with:mock&&treatment :PAA (350 µg/ml)&&
GSE185239,Wt_F_12_hpi_1,"WT strain F infection, 12 h p.i. replicate 1",Total RNA,Homo sapiens sapiens,total RNA,Total RNA prepared using Trizol,gene_counts.tsv,L1901225_Nr13_Wt_F_12_hpi_R1.fq.gz;L1901225_Nr13_Wt_F_12_hpi_R2.fq.gz,NA,NA,"Time post infection:12 hpi&&Cell type:human fetal foreskin fibroblasts&&Infection with:Herpes simplex virus 1, strain F&&treatment :no treatment&&"
GSE185239,Wt_F_12_hpi_2,"WT strain F infection, 12 h p.i. replicate 2",Total RNA,Homo sapiens sapiens,total RNA,Total RNA prepared using Trizol,gene_counts.tsv,Nr28_strain_F_12_hpi_RNA_R1.fq.gz;Nr28_strain_F_12_hpi_RNA_R2.fq.gz,NA,NA,"Time post infection:12 hpi&&Cell type:human fetal foreskin fibroblasts&&Infection with:Herpes simplex virus 1, strain F&&treatment :no treatment&&"
GSE185239,Wt_F_12_hpi_plus_12hPAA_1,"WT strain F infection, 12 h p.i., PAA,  replicate 1",Total RNA,Homo sapiens sapiens,total RNA,Total RNA prepared using Trizol,gene_counts.tsv,L1901226_Nr14_Wt_F_12_hpi_plus_12hPAA_R1.fq.gz;L1901226_Nr14_Wt_F_12_hpi_plus_12hPAA_R2.fq.gz,NA,NA,"Time post infection:12 hpi&&Cell type:human fetal foreskin fibroblasts&&Infection with:Herpes simplex virus 1, strain F&&treatment :PAA (350 µg/ml)&&"
GSE185239,Wt_F_12_hpi_plus_12hPAA_2,"WT strain F infection, 12 h p.i., PAA,  replicate 2",Total RNA,Homo sapiens sapiens,total RNA,Total RNA prepared using Trizol,gene_counts.tsv,Nr29_strain_F_12_hpi+PAA_RNA_R1.fq.gz;Nr29_strain_F_12_hpi+PAA_RNA_R2.fq.gz,NA,NA,"Time post infection:12 hpi&&Cell type:human fetal foreskin fibroblasts&&Infection with:Herpes simplex virus 1, strain F&&treatment :PAA (350 µg/ml)&&"
GSE185239,Wt_F_8_hpi_1,"WT strain F infection, 8 h p.i. replicate 1",Total RNA,Homo sapiens sapiens,total RNA,Total RNA prepared using Trizol,gene_counts.tsv,L1901219_Nr05_Wt_F_8_hpi_R1.fq.gz;L1901219_Nr05_Wt_F_8_hpi_R2.fq.gz,NA,NA,"Time post infection:8 hpi&&Cell type:human fetal foreskin fibroblasts&&Infection with:Herpes simplex virus 1, strain F&&treatment :no treatment&&"
GSE185239,Wt_F_8_hpi_plus_8hPAA_1,"WT strain F infection, 8 h p.i., PAA, replicate 1",Total RNA,Homo sapiens sapiens,total RNA,Total RNA prepared using Trizol,gene_counts.tsv,L1901220_Nr06_Wt_F_8_hpi_plus_8hPAA_R1.fq.gz;L1901220_Nr06_Wt_F_8_hpi_plus_8hPAA_R2.fq.gz,NA,NA,"Time post infection:8 hpi&&Cell type:human fetal foreskin fibroblasts&&Infection with:Herpes simplex virus 1, strain F&&treatment :PAA (350 µg/ml)&&"
GSE185239,Wt_F_8_hpi_plus_8hPAA_2,"WT strain F infection, 8 h p.i., PAA, replicate 2",Total RNA,Homo sapiens sapiens,total RNA,Total RNA prepared using Trizol,gene_counts.tsv,Nr23_strain_F_8hpi+PAA_RNA_R1.fq.gz;Nr23_strain_F_8hpi+PAA_RNA_R2.fq.gz,NA,NA,"Time post infection:8 hpi&&Cell type:human fetal foreskin fibroblasts&&Infection with:Herpes simplex virus 1, strain F&&treatment :PAA (350 µg/ml)&&"
GSE185239,Wt_F_8hpi_2,"WT strain F infection, 8 h p.i. replicate 2",Total RNA,Homo sapiens sapiens,total RNA,Total RNA prepared using Trizol,gene_counts.tsv,Nr22_strain_F_8hpi_RNA_R1.fq.gz;Nr22_strain_F_8hpi_RNA_R2.fq.gz,NA,NA,"Time post infection:8 hpi&&Cell type:human fetal foreskin fibroblasts&&Infection with:Herpes simplex virus 1, strain F&&treatment :no treatment&&"
GSE185240,TH4_ICP22_1,"GFP-expressing HH-TERT cells, infected with US1 deletion mutant HSV-1 strain 17, 8 hpi, replicate 1",Omin-ATAC-seq,homo sapiens,NA,NA,TH4_ICP22_1.bedgraph,TH4_ICP22_R1.fq.gz;TH4_ICP22_R2.fq.gz,NA,NA,cell line:HFF-TERT cells doxycycline-inducibly expressing GFP (control sample)&&Virus strain:HSV-1(17+)Lox BAC derived US1 deletion mutant&&:infected with US1 mutant&&
GSE185240,TH4_ICP22_2,"GFP-expressing HH-TERT cells, infected with US1 deletion mutant HSV-1 strain 17, 8 hpi, replicate 2",Omin-ATAC-seq,homo sapiens,NA,NA,TH4_ICP22_2.bedgraph,TH4_ICP22_rep_2_R1.fq.gz;TH4_ICP22_rep_2_R2.fq.gz,NA,NA,cell line:HFF-TERT cells doxycycline-inducibly expressing GFP (control sample)&&Virus strain:HSV-1(17+)Lox BAC derived US1 deletion mutant&&:infected with US1 mutant&&
GSE185240,TH4_Mock1_1,"GFP-expressing HH-TERT cells, mock-infected, 8 hpi, replicate 1",Omin-ATAC-seq,homo sapiens,NA,NA,TH4_Mock1_1.bedgraph,TH4_Mock1_R1.fq.gz;TH4_Mock1_R2.fq.gz,NA,NA,cell line:HFF-TERT cells doxycycline-inducibly expressing GFP (control sample)&&:mock infected&&
GSE185240,TH4_Mock1_2,"GFP-expressing HH-TERT cells, mock-infected, 8 hpi, replicate 2",Omin-ATAC-seq,homo sapiens,NA,NA,TH4_Mock1_2.bedgraph,TH4_Mock1_rep_2_R1.fq.gz;TH4_Mock1_rep_2_R2.fq.gz,NA,NA,cell line:HFF-TERT cells doxycycline-inducibly expressing GFP (control sample)&&:mock infected&&
GSE185240,TH4_WT_1,"GFP-expressing HH-TERT cells, infected with BAC-derived WT HSV-1 strain 17, 8 hpi, replicate 1",Omin-ATAC-seq,homo sapiens,NA,NA,TH4_WT_1.bedgraph,TH4_WT_R1.fq.gz;TH4_WT_R2.fq.gz,NA,NA,cell line:HFF-TERT cells doxycycline-inducibly expressing GFP (control sample)&&Virus strain:HSV-1(17+)Lox BAC derived WT virus&&:infected with parental BAC derived wt virus&&
GSE185240,TH4_WT_2,"GFP-expressing HH-TERT cells, infected with BAC-derived WT HSV-1 strain 17, 8 hpi, replicate 2",Omin-ATAC-seq,homo sapiens,NA,NA,TH4_WT_2.bedgraph,TH4_WT_rep_2_R1.fq.gz;TH4_WT_rep_2_R2.fq.gz,NA,NA,cell line:HFF-TERT cells doxycycline-inducibly expressing GFP (control sample)&&Virus strain:HSV-1(17+)Lox BAC derived WT virus&&:infected with parental BAC derived wt virus&&
GSE208077,PR22034,"HFF-tert, doxycycline-inducible ICP22, 5ug/ml doxycycline for 24h, 200mM KCl for 2h, rep1",NA,Homo sapiens sapiens,DNA,ICP22_dox_KCl_R1,ICP22_dox_KCl_R1.bedgraph,ICP22_dox_KCl_R1_R1.fq.gz;ICP22_dox_KCl_R1_R2.fq.gz,paired-end,NextSeq 500,"tissue:foreskin&&cell line:HFF-tert (telomerase-immortalized), transduced with lentivirus containing an inducible ICP22 cassette and rtTA3&&cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&treatment:5ug/ml doxycycline for 24h, 200mM KCl for 2h&&"
GSE208077,PR22034,"HFF-tert, doxycycline-inducible ICP22, 5ug/ml doxycycline for 24h, 200mM KCl for 2h, rep2",NA,Homo sapiens sapiens,DNA,ICP22_dox_KCl_R2,ICP22_dox_KCl_R2.bedgraph,ICP22_dox_KCl_R2_R1.fq.gz;ICP22_dox_KCl_R2_R2.fq.gz,paired-end,NextSeq 500,"tissue:foreskin&&cell line:HFF-tert (telomerase-immortalized), transduced with lentivirus containing an inducible ICP22 cassette and rtTA3&&cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&treatment:5ug/ml doxycycline for 24h, 200mM KCl for 2h&&"
GSE208077,PR22034,"HFF-tert, doxycycline-inducible ICP22, 5ug/ml doxycycline for 24h, no KCl, rep1",NA,Homo sapiens sapiens,DNA,ICP22_dox_R1,ICP22_dox_R1.bedgraph,ICP22_dox_R1_R1.fq.gz;ICP22_dox_R1_R2.fq.gz,paired-end,NextSeq 500,"tissue:foreskin&&cell line:HFF-tert (telomerase-immortalized), transduced with lentivirus containing an inducible ICP22 cassette and rtTA3&&cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&treatment:5ug/ml doxycycline for 24h, no KCl&&"
GSE208077,PR22034,"HFF-tert, doxycycline-inducible ICP22, 5ug/ml doxycycline for 24h, no KCl, rep2",NA,Homo sapiens sapiens,DNA,ICP22_dox_R2,ICP22_dox_R2.bedgraph,ICP22_dox_R2_R1.fq.gz;ICP22_dox_R2_R2.fq.gz,paired-end,NextSeq 500,"tissue:foreskin&&cell line:HFF-tert (telomerase-immortalized), transduced with lentivirus containing an inducible ICP22 cassette and rtTA3&&cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&treatment:5ug/ml doxycycline for 24h, no KCl&&"
GSE208077,PR22034,"HFF-tert, doxycycline-inducible ICP22, no doxycycline, 200mM KCl for 2h, rep1",NA,Homo sapiens sapiens,DNA,ICP22_no_dox_KCl_R1,ICP22_no_dox_KCl_R1.bedgraph,ICP22_no_dox_KCl_R1_R1.fq.gz;ICP22_no_dox_KCl_R1_R2.fq.gz,paired-end,NextSeq 500,"tissue:foreskin&&cell line:HFF-tert (telomerase-immortalized), transduced with lentivirus containing an inducible ICP22 cassette and rtTA3&&cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&treatment:no doxycycline, 200mM KCl for 2h&&"
GSE208077,PR22034,"HFF-tert, doxycycline-inducible ICP22, no doxycycline, 200mM KCl for 2h, rep2",NA,Homo sapiens sapiens,DNA,ICP22_no_dox_KCl_R2,ICP22_no_dox_KCl_R2.bedgraph,ICP22_no_dox_KCl_R2_R1.fq.gz;ICP22_no_dox_KCl_R2_R2.fq.gz,paired-end,NextSeq 500,"tissue:foreskin&&cell line:HFF-tert (telomerase-immortalized), transduced with lentivirus containing an inducible ICP22 cassette and rtTA3&&cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&treatment:no doxycycline, 200mM KCl for 2h&&"
GSE208077,PR22034,"HFF-tert, doxycycline-inducible ICP22, no doxycycline, no KCl, rep1",NA,Homo sapiens sapiens,DNA,ICP22_no_dox_R1,ICP22_no_dox_R1.bedgraph,ICP22_no_dox_R1_R1.fq.gz;ICP22_no_dox_R1_R2.fq.gz,paired-end,NextSeq 500,"tissue:foreskin&&cell line:HFF-tert (telomerase-immortalized), transduced with lentivirus containing an inducible ICP22 cassette and rtTA3&&cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&treatment:no doxycycline, no KCl&&"
GSE208077,PR22034,"HFF-tert, doxycycline-inducible ICP22, no doxycycline, no KCl, rep2",NA,Homo sapiens sapiens,DNA,ICP22_no_dox_R2,ICP22_no_dox_R2.bedgraph,ICP22_no_dox_R2_R1.fq.gz;ICP22_no_dox_R2_R2.fq.gz,paired-end,NextSeq 500,"tissue:foreskin&&cell line:HFF-tert (telomerase-immortalized), transduced with lentivirus containing an inducible ICP22 cassette and rtTA3&&cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&treatment:no doxycycline, no KCl&&"
GSE208077,PR22034,"HFF-tert, doxycycline-inducible ICP27, 5ug/ml doxycycline for 24h, no  KCl, rep1",NA,Homo sapiens sapiens,DNA,ICP27_dox_R1,ICP27_dox_R1.bedgraph,ICP27_dox_R1_R1.fq.gz;ICP27_dox_R1_R2.fq.gz,paired-end,NextSeq 500,"tissue:foreskin&&cell line:HFF-tert (telomerase-immortalized), transduced with lentivirus containing an inducible ICP27 cassette and rtTA3&&cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&treatment:5ug/ml doxycycline for 24h, no  KCl&&"
GSE208077,PR22034,"HFF-tert, doxycycline-inducible ICP27, 5ug/ml doxycycline for 24h, no  KCl, rep2",NA,Homo sapiens sapiens,DNA,ICP27_dox_R2,ICP27_dox_R2.bedgraph,ICP27_dox_R2_R1.fq.gz;ICP27_dox_R2_R2.fq.gz,paired-end,NextSeq 500,"tissue:foreskin&&cell line:HFF-tert (telomerase-immortalized), transduced with lentivirus containing an inducible ICP27 cassette and rtTA3&&cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&treatment:5ug/ml doxycycline for 24h, no  KCl&&"
GSE208077,PR22034,"HFF-tert, doxycycline-inducible ICP27, no treatment, rep1",NA,Homo sapiens sapiens,DNA,ICP27_no_dox_R1,ICP27_no_dox_R1.bedgraph,ICP27_no_dox_R1_R1.fq.gz;ICP27_no_dox_R1_R2.fq.gz,paired-end,NextSeq 500,"tissue:foreskin&&cell line:HFF-tert (telomerase-immortalized), transduced with lentivirus containing an inducible ICP27 cassette and rtTA3&&cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&treatment:no treatment&&"
GSE208077,PR22034,"HFF-tert, doxycycline-inducible ICP27, no treatment, rep2",NA,Homo sapiens sapiens,DNA,ICP27_no_dox_R2,ICP27_no_dox_R2.bedgraph,ICP27_no_dox_R2_R1.fq.gz;ICP27_no_dox_R2_R2.fq.gz,paired-end,NextSeq 500,"tissue:foreskin&&cell line:HFF-tert (telomerase-immortalized), transduced with lentivirus containing an inducible ICP27 cassette and rtTA3&&cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&treatment:no treatment&&"
GSE208078,"ICP22/27 OE, salt stress","HFF-tert doxycycline-inducible ICP22, 5ug/ml doxycycline for 24h, 200mM KCl for 2h, rep1",NA,Homo sapiens sapiens,total RNA,ICP22_dox_KCl_rep1,gene_counts.tsv,ICP22_dox_KCl_R1.fq.gz,single,NextSeq 500,"tissue:foreskin&&cell line:HFF-tert (telomerase-immortalized), transduced with lentivirus containing an inducible ICP22 cassette and rtTA3&&cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&treatment:5ug/ml doxycycline for 24h, 200mM KCl for 2h&&"
GSE208078,"ICP22/27 OE, salt stress","HFF-tert doxycycline-inducible ICP22, 5ug/ml doxycycline for 24h, 200mM KCl for 2h, rep2",NA,Homo sapiens sapiens,total RNA,ICP22_dox_KCl_rep2,gene_counts.tsv,ICP22_dox_KCl_R2.fq.gz,single,NextSeq 500,"tissue:foreskin&&cell line:HFF-tert (telomerase-immortalized), transduced with lentivirus containing an inducible ICP22 cassette and rtTA3&&cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&treatment:5ug/ml doxycycline for 24h, 200mM KCl for 2h&&"
GSE208078,"ICP22/27 OE, salt stress","HFF-tert doxycycline-inducible ICP22, 5ug/ml doxycycline for 24h, no KCl, rep1",NA,Homo sapiens sapiens,total RNA,ICP22_dox_rep1,gene_counts.tsv,ICP22_dox_R1.fq.gz,single,NextSeq 500,"tissue:foreskin&&cell line:HFF-tert (telomerase-immortalized), transduced with lentivirus containing an inducible ICP22 cassette and rtTA3&&cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&treatment:5ug/ml doxycycline for 24h, no KCl&&"
GSE208078,"ICP22/27 OE, salt stress","HFF-tert doxycycline-inducible ICP22, 5ug/ml doxycycline for 24h, no KCl, rep2",NA,Homo sapiens sapiens,total RNA,ICP22_dox_rep2,gene_counts.tsv,ICP22_dox_R2.fq.gz,single,NextSeq 500,"tissue:foreskin&&cell line:HFF-tert (telomerase-immortalized), transduced with lentivirus containing an inducible ICP22 cassette and rtTA3&&cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&treatment:5ug/ml doxycycline for 24h, no KCl&&"
GSE208078,"ICP22/27 OE, salt stress","HFF-tert doxycycline-inducible ICP22, no doxycycline, 200mM KCl for 2h, rep1",NA,Homo sapiens sapiens,total RNA,ICP22_no_dox_KCl_rep1,gene_counts.tsv,ICP22_no_dox_KCl_R1.fq.gz,single,NextSeq 500,"tissue:foreskin&&cell line:HFF-tert (telomerase-immortalized), transduced with lentivirus containing an inducible ICP22 cassette and rtTA3&&cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&treatment:no doxycycline, 200mM KCl for 2h&&"
GSE208078,"ICP22/27 OE, salt stress","HFF-tert doxycycline-inducible ICP22, no doxycycline, 200mM KCl for 2h, rep2",NA,Homo sapiens sapiens,total RNA,ICP22_no_dox_KCl_rep2,gene_counts.tsv,ICP22_no_dox_KCl_R2.fq.gz,single,NextSeq 500,"tissue:foreskin&&cell line:HFF-tert (telomerase-immortalized), transduced with lentivirus containing an inducible ICP22 cassette and rtTA3&&cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&treatment:no doxycycline, 200mM KCl for 2h&&"
GSE208078,"ICP22/27 OE, salt stress","HFF-tert doxycycline-inducible ICP22, no doxycycline, no KCl, rep1",NA,Homo sapiens sapiens,total RNA,ICP22_no_dox_rep1,gene_counts.tsv,ICP22_no_dox_R1.fq.gz,single,NextSeq 500,"tissue:foreskin&&cell line:HFF-tert (telomerase-immortalized), transduced with lentivirus containing an inducible ICP22 cassette and rtTA3&&cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&treatment:no doxycycline, no KCl&&"
GSE208078,"ICP22/27 OE, salt stress","HFF-tert doxycycline-inducible ICP22, no doxycycline, no KCl, rep2",NA,Homo sapiens sapiens,total RNA,ICP22_no_dox_rep2,gene_counts.tsv,ICP22_no_dox_R2.fq.gz,single,NextSeq 500,"tissue:foreskin&&cell line:HFF-tert (telomerase-immortalized), transduced with lentivirus containing an inducible ICP22 cassette and rtTA3&&cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&treatment:no doxycycline, no KCl&&"
GSE208078,"ICP22/27 OE, salt stress","HFF-tert doxycycline-inducible ICP27, 5ug/ml doxycycline for 24h, no KCl, rep1",NA,Homo sapiens sapiens,total RNA,ICP27_dox_rep1,gene_counts.tsv,ICP27_dox_R1.fq.gz,single,NextSeq 500,"tissue:foreskin&&cell line:HFF-tert (telomerase-immortalized), transduced with lentivirus containing an inducible ICP27 cassette and rtTA3&&cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&treatment:5ug/ml doxycycline for 24h, no KCl&&"
GSE208078,"ICP22/27 OE, salt stress","HFF-tert doxycycline-inducible ICP27, 5ug/ml doxycycline for 24h, no KCl, rep2",NA,Homo sapiens sapiens,total RNA,ICP27_dox_rep2,gene_counts.tsv,ICP27_dox_R2.fq.gz,single,NextSeq 500,"tissue:foreskin&&cell line:HFF-tert (telomerase-immortalized), transduced with lentivirus containing an inducible ICP27 cassette and rtTA3&&cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&treatment:5ug/ml doxycycline for 24h, no KCl&&"
GSE208078,"ICP22/27 OE, salt stress","HFF-tert doxycycline-inducible ICP27, no doxycycline, no KCl, rep1",NA,Homo sapiens sapiens,total RNA,ICP27_no_dox_rep1,gene_counts.tsv,ICP27_no_dox_R1.fq.gz,single,NextSeq 500,"tissue:foreskin&&cell line:HFF-tert (telomerase-immortalized), transduced with lentivirus containing an inducible ICP27 cassette and rtTA3&&cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&treatment:no doxycycline, no KCl&&"
GSE208078,"ICP22/27 OE, salt stress","HFF-tert doxycycline-inducible ICP27, no doxycycline, no KCl, rep2",NA,Homo sapiens sapiens,total RNA,ICP27_no_dox_rep2,gene_counts.tsv,ICP27_no_dox_R2.fq.gz,single,NextSeq 500,"tissue:foreskin&&cell line:HFF-tert (telomerase-immortalized), transduced with lentivirus containing an inducible ICP27 cassette and rtTA3&&cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&treatment:no doxycycline, no KCl&&"
GSE208078,SSRP1 KD,"HFF-tert doxycycline-inducible artificial miRNA against SSRP1 (amiRNA1) Mock, +PAA, 8 hpi, Mock, no doxycycline, rep1",NA,Homo sapiens sapiens,total RNA,Mock_minus_dox_rep1,gene_counts.tsv,Mock_minus_dox_R1.fq.gz,single,NextSeq 500,"tissue:foreskin&&cell line:HFF-tert (telomerase-immortalized), transduced with lentivirus containing an inducible artificial miRNA against SSRP1 (amiRNA1)&&cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&treatment:no doxycycline, 350 ug/ml PAA supplemented upon removal of inoculum (8h treatment)&&Time post infection:Mock, +PAA, 8 hpi&&Infection with:Mock&&"
GSE208078,SSRP1 KD,"HFF-tert doxycycline-inducible artificial miRNA against SSRP1 (amiRNA2) Mock, +PAA, 8 hpi, Mock, no doxycycline, rep2",NA,Homo sapiens sapiens,total RNA,Mock_minus_dox_rep2,gene_counts.tsv,Mock_minus_dox_R2.fq.gz,single,NextSeq 500,"tissue:foreskin&&cell line:HFF-tert (telomerase-immortalized), transduced with lentivirus containing an inducible artificial miRNA against SSRP1 (amiRNA2)&&cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&treatment:no doxycycline, 350 ug/ml PAA supplemented upon removal of inoculum (8h treatment)&&Time post infection:Mock, +PAA, 8 hpi&&Infection with:Mock&&"
GSE208078,SSRP1 KD,"HFF-tert doxycycline-inducible artificial miRNA against SSRP1 (amiRNA1) Mock, +PAA, 8 hpi, Mock, 5ug/ml doxycycline for 24 h, rep1",NA,Homo sapiens sapiens,total RNA,Mock_plus_dox_rep1,gene_counts.tsv,Mock_plus_dox_R1.fq.gz,single,NextSeq 500,"tissue:foreskin&&cell line:HFF-tert (telomerase-immortalized), transduced with lentivirus containing an inducible artificial miRNA against SSRP1 (amiRNA1)&&cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&treatment:5ug/ml  doxycycline for 24 h, 350 ug/ml PAA supplemented upon removal of inoculum (8h treatment)&&Time post infection:Mock, +PAA, 8 hpi&&Infection with:Mock&&"
GSE208078,SSRP1 KD,"HFF-tert doxycycline-inducible artificial miRNA against SSRP1 (amiRNA2) Mock, +PAA, 8 hpi, Mock, 5ug/ml doxycycline for 24 h, rep2",NA,Homo sapiens sapiens,total RNA,Mock_plus_dox_rep2,gene_counts.tsv,Mock_plus_dox_R2.fq.gz,single,NextSeq 500,"tissue:foreskin&&cell line:HFF-tert (telomerase-immortalized), transduced with lentivirus containing an inducible artificial miRNA against SSRP1 (amiRNA2)&&cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&treatment:5ug/ml  doxycycline for 24 h, 350 ug/ml PAA supplemented upon removal of inoculum (8h treatment)&&Time post infection:Mock, +PAA, 8 hpi&&Infection with:Mock&&"
GSE208078,SSRP1 KD,"HFF-tert doxycycline-inducible artificial miRNA against SSRP1 (amiRNA1) 8 hpi, +PAA, HSV-1, strain F, no doxycycline, rep1",NA,Homo sapiens sapiens,total RNA,Wt_minus_dox_rep1,gene_counts.tsv,Wt_minus_dox_R1.fq.gz,single,NextSeq 500,"tissue:foreskin&&cell line:HFF-tert (telomerase-immortalized), transduced with lentivirus containing an inducible artificial miRNA against SSRP1 (amiRNA1)&&cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&treatment:no doxycycline, 350 ug/ml PAA supplemented upon removal of inoculum (8h treatment)&&Time post infection:8 hpi, +PAA&&Infection with:HSV-1, strain F&&"
GSE208078,SSRP1 KD,"HFF-tert doxycycline-inducible artificial miRNA against SSRP1 (amiRNA2) 8 hpi, +PAA, HSV-1, strain F, no doxycycline, rep2",NA,Homo sapiens sapiens,total RNA,Wt_minus_dox_rep2,gene_counts.tsv,Wt_minus_dox_R2.fq.gz,single,NextSeq 500,"tissue:foreskin&&cell line:HFF-tert (telomerase-immortalized), transduced with lentivirus containing an inducible artificial miRNA against SSRP1 (amiRNA2)&&cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&treatment:no doxycycline, 350 ug/ml PAA supplemented upon removal of inoculum (8h treatment)&&Time post infection:8 hpi, +PAA&&Infection with:HSV-1, strain F&&"
GSE208078,SSRP1 KD,"HFF-tert doxycycline-inducible artificial miRNA against SSRP1 (amiRNA1) 8 hpi, +PAA, HSV-1, strain F, 5ug/ml doxycycline for 24 h, rep1",NA,Homo sapiens sapiens,total RNA,Wt_plus_dox_rep1,gene_counts.tsv,Wt_plus_dox_R1.fq.gz,single,NextSeq 500,"tissue:foreskin&&cell line:HFF-tert (telomerase-immortalized), transduced with lentivirus containing an inducible artificial miRNA against SSRP1 (amiRNA1)&&cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&treatment:5ug/ml  doxycycline for 24 h, 350 ug/ml PAA supplemented upon removal of inoculum (8h treatment)&&Time post infection:8 hpi, +PAA&&Infection with:HSV-1, strain F&&"
GSE208078,SSRP1 KD,"HFF-tert doxycycline-inducible artificial miRNA against SSRP1 (amiRNA2) 8 hpi, +PAA, HSV-1, strain F, 5ug/ml doxycycline for 24 h, rep2",NA,Homo sapiens sapiens,total RNA,Wt_plus_dox_rep2,gene_counts.tsv,Wt_plus_dox_R2.fq.gz,single,NextSeq 500,"tissue:foreskin&&cell line:HFF-tert (telomerase-immortalized), transduced with lentivirus containing an inducible artificial miRNA against SSRP1 (amiRNA2)&&cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&treatment:5ug/ml  doxycycline for 24 h, 350 ug/ml PAA supplemented upon removal of inoculum (8h treatment)&&Time post infection:8 hpi, +PAA&&Infection with:HSV-1, strain F&&"
GSE208078,SSRP1 KD,"HFF-tert doxycycline-inducible artificial miRNA against SSRP1 (amiRNA1) 8 hpi, +PAA, HSV-1, strain F, US1 deleted, no doxycycline, rep1",NA,Homo sapiens sapiens,total RNA,ICP22_minus_dox_rep1,gene_counts.tsv,ICP22_minus_dox_R1.fq.gz,single,NextSeq 500,"tissue:foreskin&&cell line:HFF-tert (telomerase-immortalized), transduced with lentivirus containing an inducible artificial miRNA against SSRP1 (amiRNA1)&&cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&treatment:no doxycycline, 350 ug/ml PAA supplemented upon removal of inoculum (8h treatment)&&Time post infection:8 hpi, +PAA&&Infection with:HSV-1, strain F, US1 deleted&&"
GSE208078,SSRP1 KD,"HFF-tert doxycycline-inducible artificial miRNA against SSRP1 (amiRNA2) 8 hpi, +PAA, HSV-1, strain F, US1 deleted, no doxycycline, rep2",NA,Homo sapiens sapiens,total RNA,ICP22_minus_dox_rep2,gene_counts.tsv,ICP22_minus_dox_R2.fq.gz,single,NextSeq 500,"tissue:foreskin&&cell line:HFF-tert (telomerase-immortalized), transduced with lentivirus containing an inducible artificial miRNA against SSRP1 (amiRNA2)&&cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&treatment:no doxycycline, 350 ug/ml PAA supplemented upon removal of inoculum (8h treatment)&&Time post infection:8 hpi, +PAA&&Infection with:HSV-1, strain F, US1 deleted&&"
GSE208078,SSRP1 KD,"HFF-tert doxycycline-inducible artificial miRNA against SSRP1 (amiRNA1) 8 hpi, +PAA, HSV-1, strain F, US1 deleted, 5ug/ml doxycycline for 24 h, rep1",NA,Homo sapiens sapiens,total RNA,ICP22_plus_dox_rep1,gene_counts.tsv,ICP22_plus_dox_R1.fq.gz,single,NextSeq 500,"tissue:foreskin&&cell line:HFF-tert (telomerase-immortalized), transduced with lentivirus containing an inducible artificial miRNA against SSRP1 (amiRNA1)&&cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&treatment:5ug/ml  doxycycline for 24 h, 350 ug/ml PAA supplemented upon removal of inoculum (8h treatment)&&Time post infection:8 hpi, +PAA&&Infection with:HSV-1, strain F, US1 deleted&&"
GSE208078,SSRP1 KD,"HFF-tert doxycycline-inducible artificial miRNA against SSRP1 (amiRNA2) 8 hpi, +PAA, HSV-1, strain F, US1 deleted, 5ug/ml doxycycline for 24 h, rep2",NA,Homo sapiens sapiens,total RNA,ICP22_plus_dox_rep2,gene_counts.tsv,ICP22_plus_dox_R2.fq.gz,single,NextSeq 500,"tissue:foreskin&&cell line:HFF-tert (telomerase-immortalized), transduced with lentivirus containing an inducible artificial miRNA against SSRP1 (amiRNA2)&&cell type:Human telomerase reverse transcriptase (hTERT)-Immortalized cell line&&treatment:5ug/ml  doxycycline for 24 h, 350 ug/ml PAA supplemented upon removal of inoculum (8h treatment)&&Time post infection:8 hpi, +PAA&&Infection with:HSV-1, strain F, US1 deleted&&"
GSE212820,2018-10-10_Lars_Doelken,"mock infection, replicate 1",NA,human,transposon tagged DNA,Mock_1,Mock_1.bedgraph,Mock_1_R1.fq.gz;Mock_1_R2.fq.gz,paired-end,Illumina NextSeq 500,tissue:human fetal foreskin fibroblasts&&cell line:human fetal foreskin fibroblasts&&time post infection:no infection&&Library Strategy:ATAC-seq&&GEO accession number:GSM5608518&&
GSE212820,2018-10-10_Lars_Doelken,"mock infection, replicate 2",NA,human,transposon tagged DNA,Mock_2,Mock_2.bedgraph,Mock_2_R1.fq.gz;Mock_2_R2.fq.gz,paired-end,Illumina NextSeq 500,tissue:human fetal foreskin fibroblasts&&cell line:human fetal foreskin fibroblasts&&time post infection:no infection&&Library Strategy:ATAC-seq&&GEO accession number:GSM5608519&&
GSE212820,2018-10-10_Lars_Doelken,"HSV-1 wt, strain 17, replicate 1",NA,human,transposon tagged DNA,WT_1,WT_1.bedgraph,WT_1_R1.fq.gz;WT_1_R2.fq.gz,paired-end,Illumina NextSeq 500,tissue:human fetal foreskin fibroblasts&&cell line:human fetal foreskin fibroblasts&&time post infection:8 hpi&&HSV-1 strain:strain 17&&Library Strategy:ATAC-seq&&GEO accession number:GSM5608520&&
GSE212820,2018-10-10_Lars_Doelken,"HSV-1 wt, strain 17, replicate 2",NA,human,transposon tagged DNA,WT_2,WT_2.bedgraph,WT_2_R1.fq.gz;WT_2_R2.fq.gz,paired-end,Illumina NextSeq 500,tissue:human fetal foreskin fibroblasts&&cell line:human fetal foreskin fibroblasts&&time post infection:8 hpi&&HSV-1 strain:strain 17&&Library Strategy:ATAC-seq&&GEO accession number:GSM5608521&&
GSE212820,2019-10-10_Lars_Doelken,"HSV-1 wt, strain 17, +PAA, replicate 1",NA,human,transposon tagged DNA,WT_plus_PAA_1,WT_plus_PAA_1.bedgraph,WT_plus_PAA_1_R1.fq.gz;WT_plus_PAA_1_R2.fq.gz,paired-end,Illumina NextSeq 500,tissue:human fetal foreskin fibroblasts&&cell line:human fetal foreskin fibroblasts&&treatment:PAA 300ug/ml&&time post infection:9 hpi&&HSV-1 strain:strain 17&&Library Strategy:ATAC-seq&&GEO accession number:GSM5608522&&
GSE212820,2020-10-10_Lars_Doelken,"HSV-1 wt, strain 17, +PAA, replicate 2",NA,human,transposon tagged DNA,WT_plus_PAA_2,WT_plus_PAA_2.bedgraph,WT_plus_PAA_2_R1.fq.gz;WT_plus_PAA_2_R2.fq.gz,paired-end,Illumina NextSeq 500,tissue:human fetal foreskin fibroblasts&&cell line:human fetal foreskin fibroblasts&&treatment:PAA 300ug/ml&&time post infection:10 hpi&&HSV-1 strain:strain 17&&Library Strategy:ATAC-seq&&GEO accession number:GSM5608523&&
GSE212820,2018-10-10_Lars_Doelken,"HSV-1 lacking expression of ICP0, replicate 1",NA,human,transposon tagged DNA,dICP0_1,dICP0_1.bedgraph,dICP0_1_R1.fq.gz;dICP0_1_R2.fq.gz,paired-end,Illumina NextSeq 500,"tissue:human fetal foreskin fibroblasts&&cell line:human fetal foreskin fibroblasts&&time post infection:12 hpi&&HSV-1 strain:strain 17, dl1403&&Library Strategy:ATAC-seq&&GEO accession number:GSM5608524&&"
GSE212820,2018-10-10_Lars_Doelken,"HSV-1 lacking expression of ICP0, replicate 2",NA,human,transposon tagged DNA,dICP0_2,dICP0_2.bedgraph,dICP0_2_R1.fq.gz;dICP0_2_R2.fq.gz,paired-end,Illumina NextSeq 500,"tissue:human fetal foreskin fibroblasts&&cell line:human fetal foreskin fibroblasts&&time post infection:12 hpi&&HSV-1 strain:strain 17, dl1403&&Library Strategy:ATAC-seq&&GEO accession number:GSM5608525&&"
GSE212820,2018-10-10_Lars_Doelken,"HSV-1 lacking expression of ICP22, HSV-1 strain F mutant R325, replicate 1",NA,human,transposon tagged DNA,dICP22_1,dICP22_1.bedgraph,dICP22_1_R1.fq.gz;dICP22_1_R2.fq.gz,paired-end,Illumina NextSeq 500,"tissue:human fetal foreskin fibroblasts&&cell line:human fetal foreskin fibroblasts&&time post infection:12 hpi&&HSV-1 strain:strain F, R325&&Library Strategy:ATAC-seq&&GEO accession number:GSM5608526&&"
GSE212820,2018-10-10_Lars_Doelken,"HSV-1 lacking expression of ICP22, HSV-1 strain F mutant R325, replicate 2",NA,human,transposon tagged DNA,dICP22_2,dICP22_2.bedgraph,dICP22_2_R1.fq.gz;dICP22_2_R2.fq.gz,paired-end,Illumina NextSeq 500,"tissue:human fetal foreskin fibroblasts&&cell line:human fetal foreskin fibroblasts&&time post infection:12 hpi&&HSV-1 strain:strain F, R325&&Library Strategy:ATAC-seq&&GEO accession number:GSM5608527&&"
GSE212820,2018-10-10_Lars_Doelken,"HSV-1 lacking expression of ICP22, HSV-1 strain F mutant R325, replicate 3",NA,human,transposon tagged DNA,dICP22_3,dICP22_3.bedgraph,dICP22_3_R1.fq.gz;dICP22_3_R2.fq.gz,paired-end,Illumina NextSeq 500,"tissue:human fetal foreskin fibroblasts&&cell line:human fetal foreskin fibroblasts&&time post infection:12 hpi&&HSV-1 strain:strain F, R325&&Library Strategy:ATAC-seq&&GEO accession number:GSM5608528&&"
GSE212820,2018-10-10_Lars_Doelken,"HSV-1 lacking expression of ICP22, HSV-1 strain F mutant R325, replicate 4",NA,human,transposon tagged DNA,dICP22_4,dICP22_4.bedgraph,dICP22_4_R1.fq.gz;dICP22_4_R2.fq.gz,paired-end,Illumina NextSeq 500,"tissue:human fetal foreskin fibroblasts&&cell line:human fetal foreskin fibroblasts&&time post infection:12 hpi&&HSV-1 strain:strain F, R325&&Library Strategy:ATAC-seq&&GEO accession number:GSM5608529&&"
GSE212820,2018-10-10_Lars_Doelken,"HSV-1 lacking expression of ICP27, KOS, replicate 1",NA,human,transposon tagged DNA,dICP27_1,dICP27_1.bedgraph,dICP27_1_R1.fq.gz;dICP27_1_R2.fq.gz,paired-end,Illumina NextSeq 500,"tissue:human fetal foreskin fibroblasts&&cell line:human fetal foreskin fibroblasts&&time post infection:8 hpi&&HSV-1 strain:strain KOS, 27LacZ&&Library Strategy:ATAC-seq&&GEO accession number:GSM5608532&&"
GSE212820,2018-10-10_Lars_Doelken,"HSV-1 lacking expression of ICP27, KOS, replicate 2",NA,human,transposon tagged DNA,dICP27_2,dICP27_2.bedgraph,dICP27_2_R1.fq.gz;dICP27_2_R2.fq.gz,paired-end,Illumina NextSeq 500,"tissue:human fetal foreskin fibroblasts&&cell line:human fetal foreskin fibroblasts&&time post infection:8 hpi&&HSV-1 strain:strain KOS, 27LacZ&&Library Strategy:ATAC-seq&&GEO accession number:GSM5608533&&"
GSE212820,2018-10-10_Lars_Doelken,"HSV-1 lacking expression of UL41, replicate 1",NA,human,transposon tagged DNA,dVHS_1,dVHS_1.bedgraph,dVHS_1_R1.fq.gz;dVHS_1_R2.fq.gz,paired-end,Illumina NextSeq 500,"tissue:human fetal foreskin fibroblasts&&cell line:human fetal foreskin fibroblasts&&time post infection:8 hpi&&HSV-1 strain:strain 17, delta-vhs&&Library Strategy:ATAC-seq&&GEO accession number:GSM5608534&&"
GSE212820,2018-10-10_Lars_Doelken,"HSV-1 lacking expression of UL41, replicate 2",NA,human,transposon tagged DNA,dVHS_2,dVHS_2.bedgraph,dVHS_2_R1.fq.gz;dVHS_2_R2.fq.gz,paired-end,Illumina NextSeq 500,"tissue:human fetal foreskin fibroblasts&&cell line:human fetal foreskin fibroblasts&&time post infection:8 hpi&&HSV-1 strain:strain 17, delta-vhs&&Library Strategy:ATAC-seq&&GEO accession number:GSM5608535&&"
GSE212820,2018-10-10_Lars_Doelken,"HSV-1 lacking expression of ICP4, replicate 1",NA,human,transposon tagged DNA,ICP4KO_1,ICP4KO_1.bedgraph,ICP4KO_1_R1.fq.gz;ICP4KO_1_R2.fq.gz,paired-end,Illumina NextSeq 500,"tissue:human fetal foreskin fibroblasts&&cell line:human fetal foreskin fibroblasts&&time post infection:8 hpi&&HSV-1 strain:strain KOS, n12 (delta-ICP4)&&Library Strategy:ATAC-seq&&"
GSE212820,2018-10-10_Lars_Doelken,"HSV-1 lacking expression of ICP4, replicate 2",NA,human,transposon tagged DNA,ICP4KO_2,ICP4KO_2.bedgraph,ICP4KO_2_R1.fq.gz;ICP4KO_2_R2.fq.gz,paired-end,Illumina NextSeq 500,"tissue:human fetal foreskin fibroblasts&&cell line:human fetal foreskin fibroblasts&&time post infection:8 hpi&&HSV-1 strain:strain KOS, n12 (delta-ICP4)&&Library Strategy:ATAC-seq&&"
GSE185246,HSV1_17_WT_8h_PAA_H1_1,"HFFF cells infected with HSV-1 WT (17), 8hpi, PAA treated, histone H1, replicate 1",ChIPmentation,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,HSV1_17_WT_8h_PAA_H1_1.bedgraph,210730_M075_V350022578_L02_580_1.fq.gz;210730_M075_V350022578_L02_580_2.fq.gz,NA,NA,"Cell type:Human fetal foreskin fibroblasts&&Treatment :PAA (350 µg/ml)&&Infection:HSV-1 WT, strain 17&&nan:210730_M075_V350022578_L03_580_2.fq.gz&&"
GSE185246,HSV1_17_WT_8h_PAA_H1_2,"HFFF cells infected with HSV-1 WT (17), 8hpi, PAA treated, histone H1, replicate 2",ChIPmentation,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,HSV1_17_WT_8h_PAA_H1_2.bedgraph,210730_M075_V350022578_L02_592_1.fq.gz;210730_M075_V350022578_L02_592_2.fq.gz,NA,NA,"Cell type:Human fetal foreskin fibroblasts&&Treatment :PAA (350 µg/ml)&&Infection:HSV-1 WT, strain 17&&nan:210730_M075_V350022578_L03_592_2.fq.gz&&"
GSE185246,HSV1_17_WT_8h_PAA_H3_1,"HFFF cells infected with HSV-1 WT (17), 8hpi, PAA treated, histone H3, replicate 1",ChIPmentation,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,HSV1_17_WT_8h_PAA_H3_1.bedgraph,210730_M075_V350022578_L02_576_1.fq.gz;210730_M075_V350022578_L02_576_2.fq.gz,NA,NA,"Cell type:Human fetal foreskin fibroblasts&&Treatment :PAA (350 µg/ml)&&Infection:HSV-1 WT, strain 17&&nan:210730_M075_V350022578_L03_576_2.fq.gz&&"
GSE185246,HSV1_17_WT_8h_PAA_H3_2,"HFFF cells infected with HSV-1 WT (17), 8hpi, PAA treated, histone H3, replicate 2",ChIPmentation,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,HSV1_17_WT_8h_PAA_H3_2.bedgraph,210730_M075_V350022578_L02_588_1.fq.gz;210730_M075_V350022578_L02_588_2.fq.gz,NA,NA,"Cell type:Human fetal foreskin fibroblasts&&Treatment :PAA (350 µg/ml)&&Infection:HSV-1 WT, strain 17&&nan:210730_M075_V350022578_L03_588_2.fq.gz&&"
GSE185246,HSV1_17_WT_8h_PAA_H4_1,"HFFF cells infected with HSV-1 WT (17), 8hpi, PAA treated, histone H4, replicate 1",ChIPmentation,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,HSV1_17_WT_8h_PAA_H4_1.bedgraph,210730_M075_V350022578_L02_577_1.fq.gz;210730_M075_V350022578_L02_577_2.fq.gz,NA,NA,"Cell type:Human fetal foreskin fibroblasts&&Treatment :PAA (350 µg/ml)&&Infection:HSV-1 WT, strain 17&&nan:210730_M075_V350022578_L03_577_2.fq.gz&&"
GSE185246,HSV1_17_WT_8h_PAA_H4_2,"HFFF cells infected with HSV-1 WT (17), 8hpi, PAA treated, histone H4, replicate 2",ChIPmentation,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,HSV1_17_WT_8h_PAA_H4_2.bedgraph,210730_M075_V350022578_L02_589_1.fq.gz;210730_M075_V350022578_L02_589_2.fq.gz,NA,NA,"Cell type:Human fetal foreskin fibroblasts&&Treatment :PAA (350 µg/ml)&&Infection:HSV-1 WT, strain 17&&nan:210730_M075_V350022578_L03_589_2.fq.gz&&"
GSE185246,HSV1_17_WT_8h_PAA_K27_1,"HFFF cells infected with HSV-1 WT (17), 8hpi, PAA treated, histone H3K27me3, replicate 1",ChIPmentation,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,HSV1_17_WT_8h_PAA_K27_1.bedgraph,210730_M075_V350022578_L02_579_1.fq.gz;210730_M075_V350022578_L02_579_2.fq.gz,NA,NA,"Cell type:Human fetal foreskin fibroblasts&&Treatment :PAA (350 µg/ml)&&Infection:HSV-1 WT, strain 17&&nan:210730_M075_V350022578_L03_579_2.fq.gz&&"
GSE185246,HSV1_17_WT_8h_PAA_K27_2,"HFFF cells infected with HSV-1 WT (17), 8hpi, PAA treated, histone H3K27me3, replicate 2",ChIPmentation,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,HSV1_17_WT_8h_PAA_K27_2.bedgraph,210730_M075_V350022578_L02_591_1.fq.gz;210730_M075_V350022578_L02_591_2.fq.gz,NA,NA,"Cell type:Human fetal foreskin fibroblasts&&Treatment :PAA (350 µg/ml)&&Infection:HSV-1 WT, strain 17&&nan:210730_M075_V350022578_L03_591_2.fq.gz&&"
GSE185246,HSV1_17_WT_8h_PAA_K36_1,"HFFF cells infected with HSV-1 WT (17), 8hpi, PAA treated, histone H3K36me3, replicate 1",ChIPmentation,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,HSV1_17_WT_8h_PAA_K36_1.bedgraph,210730_M075_V350022578_L02_578_1.fq.gz;210730_M075_V350022578_L02_578_2.fq.gz,NA,NA,"Cell type:Human fetal foreskin fibroblasts&&Treatment :PAA (350 µg/ml)&&Infection:HSV-1 WT, strain 17&&nan:210730_M075_V350022578_L03_578_2.fq.gz&&"
GSE185246,HSV1_17_WT_8h_PAA_K36_2,"HFFF cells infected with HSV-1 WT (17), 8hpi, PAA treated, histone H3K36me3, replicate 2",ChIPmentation,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,HSV1_17_WT_8h_PAA_K36_2.bedgraph,210730_M075_V350022578_L02_590_1.fq.gz;210730_M075_V350022578_L02_590_2.fq.gz,NA,NA,"Cell type:Human fetal foreskin fibroblasts&&Treatment :PAA (350 µg/ml)&&Infection:HSV-1 WT, strain 17&&nan:210730_M075_V350022578_L03_590_2.fq.gz&&"
GSE185246,Mock_8h_PAA_H1_1,"HFFF cells mock infected, PAA treated, histone H1, replicate 1",ChIPmentation,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,Mock_8h_PAA_H1_1.bedgraph,210730_M075_V350022578_L02_573_1.fq.gz;210730_M075_V350022578_L02_573_2.fq.gz,NA,NA,Cell type:Human fetal foreskin fibroblasts&&Treatment :PAA (350 µg/ml)&&Infection:mock&&nan:210730_M075_V350022578_L03_573_2.fq.gz&&
GSE185246,Mock_8h_PAA_H1_2,"HFFF cells mock infected, PAA treated, histone H1, replicate 2",ChIPmentation,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,Mock_8h_PAA_H1_2.bedgraph,210730_M075_V350022578_L02_586_1.fq.gz;210730_M075_V350022578_L02_586_2.fq.gz,NA,NA,Cell type:Human fetal foreskin fibroblasts&&Treatment :PAA (350 µg/ml)&&Infection:mock&&nan:210730_M075_V350022578_L03_586_2.fq.gz&&
GSE185246,Mock_8h_PAA_H3_1,"HFFF cells mock infected, PAA treated, histone H3, replicate 1",ChIPmentation,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,Mock_8h_PAA_H3_1.bedgraph,210730_M075_V350022578_L02_569_1.fq.gz;210730_M075_V350022578_L02_569_2.fq.gz,NA,NA,Cell type:Human fetal foreskin fibroblasts&&Treatment :PAA (350 µg/ml)&&Infection:mock&&nan:210730_M075_V350022578_L03_569_2.fq.gz&&
GSE185246,Mock_8h_PAA_H3_2,"HFFF cells mock infected, PAA treated, histone H3, replicate 2",ChIPmentation,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,Mock_8h_PAA_H3_2.bedgraph,210730_M075_V350022578_L02_582_1.fq.gz;210730_M075_V350022578_L02_582_2.fq.gz,NA,NA,Cell type:Human fetal foreskin fibroblasts&&Treatment :PAA (350 µg/ml)&&Infection:mock&&nan:210730_M075_V350022578_L03_582_2.fq.gz&&
GSE185246,Mock_8h_PAA_H4_1,"HFFF cells mock infected, PAA treated, histone H4, replicate 1",ChIPmentation,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,Mock_8h_PAA_H4_1.bedgraph,210730_M075_V350022578_L02_570_1.fq.gz;210730_M075_V350022578_L02_570_2.fq.gz,NA,NA,Cell type:Human fetal foreskin fibroblasts&&Treatment :PAA (350 µg/ml)&&Infection:mock&&nan:210730_M075_V350022578_L03_570_2.fq.gz&&
GSE185246,Mock_8h_PAA_H4_2,"HFFF cells mock infected, PAA treated, histone H4, replicate 2",ChIPmentation,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,Mock_8h_PAA_H4_2.bedgraph,210730_M075_V350022578_L02_583_1.fq.gz;210730_M075_V350022578_L02_583_2.fq.gz,NA,NA,Cell type:Human fetal foreskin fibroblasts&&Treatment :PAA (350 µg/ml)&&Infection:mock&&nan:210730_M075_V350022578_L03_583_2.fq.gz&&
GSE185246,Mock_8h_PAA_K27_1,"HFFF cells mock infected, PAA treated, histone H3K27me3, replicate 1",ChIPmentation,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,Mock_8h_PAA_K27_1.bedgraph,210730_M075_V350022578_L02_572_1.fq.gz;210730_M075_V350022578_L02_572_2.fq.gz,NA,NA,Cell type:Human fetal foreskin fibroblasts&&Treatment :PAA (350 µg/ml)&&Infection:mock&&nan:210730_M075_V350022578_L03_572_2.fq.gz&&
GSE185246,Mock_8h_PAA_K27_2,"HFFF cells mock infected, PAA treated, histone H3K27me3, replicate 2",ChIPmentation,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,Mock_8h_PAA_K27_2.bedgraph,210730_M075_V350022578_L02_585_1.fq.gz;210730_M075_V350022578_L02_585_2.fq.gz,NA,NA,Cell type:Human fetal foreskin fibroblasts&&Treatment :PAA (350 µg/ml)&&Infection:mock&&nan:210730_M075_V350022578_L03_585_2.fq.gz&&
GSE185246,Mock_8h_PAA_K36_1,"HFFF cells mock infected, PAA treated, histone H3K36me3, replicate 1",ChIPmentation,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,Mock_8h_PAA_K36_1.bedgraph,210730_M075_V350022578_L02_571_1.fq.gz;210730_M075_V350022578_L02_571_2.fq.gz,NA,NA,Cell type:Human fetal foreskin fibroblasts&&Treatment :PAA (350 µg/ml)&&Infection:mock&&nan:210730_M075_V350022578_L03_571_2.fq.gz&&
GSE185246,Mock_8h_PAA_K36_2,"HFFF cells mock infected, PAA treated, histone H3K36me3, replicate 2",ChIPmentation,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,Mock_8h_PAA_K36_2.bedgraph,210730_M075_V350022578_L02_584_1.fq.gz;210730_M075_V350022578_L02_584_2.fq.gz,NA,NA,Cell type:Human fetal foreskin fibroblasts&&Treatment :PAA (350 µg/ml)&&Infection:mock&&nan:210730_M075_V350022578_L03_584_2.fq.gz&&
GSE185246,HSV-1_Wt_str_F_H1_1,"HFFF cells infected with HSV-1 WT (F), 8hpi, PAA treated, histone H1, replicate 1",ChIPmentation,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,HSV-1_Wt_H1_new_Invitrogen_merged_200827.bedgraph,200823_I66_V300060876_L4_HSV-1_Wt_H1_new_Invitrogen_1.fq.gz;200823_I66_V300060876_L4_HSV-1_Wt_H1_new_Invitrogen_2.fq.gz,NA,NA,"Cell type:Human fetal foreskin fibroblasts&&Treatment :PAA (350 µg/ml)&&Infection:HSV-1 WT, strain F&&nan:200913_I66_V300063186_L2_HSV-1_Wt_H1_new_Invitrogen_2.fq.gz&&"
GSE185246,HSV-1_Wt_str_F_H1_2,"HFFF cells infected with HSV-1 WT (F), 8hpi, PAA treated, histone H1, replicate 2",ChIPmentation,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,HSV-1_Wt_str_F_H1_201106_2.bedgraph,428_S1_L002_R1_001.fastq.gz;428_S1_L002_R2_001.fastq.gz,NA,NA,"Cell type:Human fetal foreskin fibroblasts&&Treatment :PAA (350 µg/ml)&&Infection:HSV-1 WT, strain F&&"
GSE185246,ICP22_H1_1,"HFFF cells infected with ΔICP22 (F), 8hpi, PAA treated, histone H1, replicate 1",ChIPmentation,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,ICP22_H1_new_Invitrogen_merged_200827.bedgraph,200823_I66_V300060876_L4_ICP22_H1_new_Invitrogen_1.fq.gz;200823_I66_V300060876_L4_ICP22_H1_new_Invitrogen_2.fq.gz,NA,NA,"Cell type:Human fetal foreskin fibroblasts&&Treatment :PAA (350 µg/ml)&&Infection:ΔICP22, strain F&&nan:200913_I66_V300063186_L2_ICP22_H1_new_Invitrogen_2.fq.gz&&"
GSE185246,ICP22_H1_2,"HFFF cells infected with ΔICP22 (F), 8hpi, PAA treated, histone H1, replicate 2",ChIPmentation,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,ICP22_H1_201106_2.bedgraph,432_S1_L002_R1_001.fastq.gz;432_S1_L002_R2_001.fastq.gz,NA,NA,"Cell type:Human fetal foreskin fibroblasts&&Treatment :PAA (350 µg/ml)&&Infection:ΔICP22, strain F&&"
GSE185246,MOCK_H1_1,"HFFF cells mock infected, PAA treated, histone H1, replicate 1",ChIPmentation,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,MOCK_H1_new_Invitrogen_merged_200827.bedgraph,200823_I66_V300060876_L4_MOCK_H1_new_Invitrogen_1.fq.gz;200823_I66_V300060876_L4_MOCK_H1_new_Invitrogen_2.fq.gz,NA,NA,Cell type:Human fetal foreskin fibroblasts&&Treatment :PAA (350 µg/ml)&&Infection:mock&&nan:210730_M075_V350022578_L03_573_2.fq.gz&&
GSE185246,MOCK_H1_2,"HFFF cells mock infected, PAA treated, histone H1, replicate 2",ChIPmentation,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,MOCK_H1_201106_2.bedgraph,424_S1_L002_R1_001.fastq.gz;424_S1_L002_R2_001.fastq.gz,NA,NA,Cell type:Human fetal foreskin fibroblasts&&Treatment :PAA (350 µg/ml)&&Infection:mock&&nan:210730_M075_V350022578_L03_586_2.fq.gz&&
GSE185246,H3_total_mock_1,"HFFF cells mock infected, histone H3, replicate 1",ChIPmentation,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,H3_total_mock_180424.bedgraph,MOCK_H3_total_R1.fq.gz;MOCK_H3_total_R2.fq.gz,NA,NA,Cell type:Human fetal foreskin fibroblasts&&Treatment :no treatment&&Infection:mock&&
GSE185246,H3_total_mock_2,"HFFF cells mock infected, histone H3, replicate 2",ChIPmentation,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,H3_total_mock_180628.bedgraph,M22_Total_H3_R1.fq.gz;M22_Total_H3_R2.fq.gz,NA,NA,Cell type:Human fetal foreskin fibroblasts&&Treatment :no treatment&&Infection:mock&&
GSE185246,H3_total_WT17_1,"HFFF cells infected with HSV-1 WT (17), histone H3, replicate 1",ChIPmentation,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,H3_total_WT17_180424.bedgraph,HSV_1_H3_total_R1.fq.gz;HSV_1_H3_total_R2.fq.gz,NA,NA,"Cell type:Human fetal foreskin fibroblasts&&Treatment :no treatment&&Infection:HSV-1 WT, strain 17&&"
GSE185246,H3_total_WT17_2,"HFFF cells infected with HSV-1 WT (17), histone H3, replicate 2",ChIPmentation,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,H3_total_WT17_180628.bedgraph,HSV27_Total_H3_R1.fq.gz;HSV27_Total_H3_R2.fq.gz,NA,NA,"Cell type:Human fetal foreskin fibroblasts&&Treatment :no treatment&&Infection:HSV-1 WT, strain 17&&"
GSE185246,H3K27me3_mock_1,"HFFF cells mock infected, histone H3K27me3, replicate 1",ChIPmentation,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,H3K27me3_mock_1.bedgraph,MOCK_H3K27me3_R1.fq.gz;MOCK_H3K27me3_R2.fq.gz,NA,NA,Cell type:Human fetal foreskin fibroblasts&&Treatment :no treatment&&Infection:mock&&
GSE185246,H3K27me3_mock_2,"HFFF cells mock infected, histone H3K27me3, replicate 2",ChIPmentation,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,H3K27me3_mock_2.bedgraph,M24_H3K27me3_R1.fq.gz;M24_H3K27me3_R2.fq.gz,NA,NA,Cell type:Human fetal foreskin fibroblasts&&Treatment :no treatment&&Infection:mock&&
GSE185246,H3K27me3_wt_1,"HFFF cells infected with HSV-1 WT (17), histone H3K27me3, replicate 1",ChIPmentation,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,H3K27me3_wt_1.bedgraph,HSV_1_H3K27me3_R1.fq.gz;HSV_1_H3K27me3_R2.fq.gz,NA,NA,"Cell type:Human fetal foreskin fibroblasts&&Treatment :no treatment&&Infection:HSV-1 WT, strain 17&&"
GSE185246,H3K27me3_wt_2,"HFFF cells infected with HSV-1 WT (17), histone H3K27me3, replicate 2",ChIPmentation,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,H3K27me3_wt_2.bedgraph,HSV29_H3K27me3_R1.fq.gz;HSV29_H3K27me3_R2.fq.gz,NA,NA,"Cell type:Human fetal foreskin fibroblasts&&Treatment :no treatment&&Infection:HSV-1 WT, strain 17&&"
GSE185246,H3K36me3_mock_1,"HFFF cells mock infected, histone H3K36me3, replicate 1",ChIPmentation,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,H3K36me3_mock_1.bedgraph,MOCK_H3K36me3_R1.fq.gz;MOCK_H3K36me3_R2.fq.gz,NA,NA,Cell type:Human fetal foreskin fibroblasts&&Treatment :no treatment&&Infection:mock&&
GSE185246,H3K36me3_mock_2,"HFFF cells mock infected, histone H3K36me3, replicate 2",ChIPmentation,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,H3K36me3_mock_2.bedgraph,M23_H3K36me3_R1.fq.gz;M23_H3K36me3_R2.fq.gz,NA,NA,Cell type:Human fetal foreskin fibroblasts&&Treatment :no treatment&&Infection:mock&&
GSE185246,H3K36me3_mock_3,"HFFF cells mock infected, histone H3K36me3, replicate 3",ChIPmentation,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,H3K36me3_mock_4.bedgraph,M43_H3K36me3_R1.fq.gz;M43_H3K36me3_R2.fq.gz,NA,NA,Cell type:Human fetal foreskin fibroblasts&&Treatment :no treatment&&Infection:mock&&
GSE185246,H3K36me3_wt_1,"HFFF cells infected with HSV-1 WT (17), histone H3K36me3, replicate 1",ChIPmentation,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,H3K36me3_wt_1.bedgraph,HSV_1_H3K36me3_R1.fq.gz;HSV_1_H3K36me3_R2.fq.gz,NA,NA,"Cell type:Human fetal foreskin fibroblasts&&Treatment :no treatment&&Infection:HSV-1 WT, strain 17&&"
GSE185246,H3K36me3_wt_2,"HFFF cells infected with HSV-1 WT (17), histone H3K36me3, replicate 2",ChIPmentation,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,H3K36me3_wt_2.bedgraph,HSV28_H3K36me3_R1.fq.gz;HSV28_H3K36me3_R2.fq.gz,NA,NA,"Cell type:Human fetal foreskin fibroblasts&&Treatment :no treatment&&Infection:HSV-1 WT, strain 17&&"
GSE185246,H3K36me3_wt_3,"HFFF cells infected with HSV-1 WT (17), histone H3K36me3, replicate 3",ChIPmentation,Homo sapiens sapiens,DNA,DNA isolated with Zymo DNA Clean & Concentrator,H3K36me3_wt_4.bedgraph,HSV48_H3K36me3_R1.fq.gz;HSV48_H3K36me3_R2.fq.gz,NA,NA,"Cell type:Human fetal foreskin fibroblasts&&Treatment :no treatment&&Infection:HSV-1 WT, strain 17&&"
